                               SEQUENCE LISTING

<110> GO THERAPEUTICS
 
<120> ANTI-GLYCO-CD44 ANTIBODIES AND THEIR USES

<130> GOT-003-WO

<140>
<141>

<150> 62/986,083
<151> 2020-03-06

<160> 262   

<170> PatentIn version 3.5

<210> 1
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 1
Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Trp Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe 
    50                  55                  60                  


Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys 
                85                  90                  95      


Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ala 
        115             


<210> 2
<211> 109
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 2
Gln Ala Val Val Thr Gln Glu Ser Ala Leu Thr Thr Ser Pro Gly Glu 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Arg Thr Ser Thr Gly Ala Val Ser Ile Arg 
            20                  25                  30          


Asn Tyr Ala Asn Trp Val Gln Glu Lys Pro Asp His Leu Phe Thr Gly 
        35                  40                  45              


Leu Ile Gly Gly Thr Asn Asn Arg Ala Pro Gly Val Pro Ala Arg Phe 
    50                  55                  60                  


Ser Gly Ser Leu Ile Gly Asp Lys Ala Ala Leu Thr Ile Thr Gly Ala 
65                  70                  75                  80  


Gln Pro Glu Asp Glu Ala Ile Tyr Phe Cys Ala Leu Leu Tyr Ser Asn 
                85                  90                  95      


Tyr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210> 3
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Gly Tyr Thr Phe Thr Ser Tyr Trp 
1               5               


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Ile Tyr Pro Arg Ser Gly Thr Thr 
1               5               


<210> 5
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
1               5                   10      


<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Thr Gly Ala Val Ser Ile Arg Asn Tyr 
1               5                   


<210> 7
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Gly Thr Asn 
1           


<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Ala Leu Leu Tyr Ser Asn Tyr Trp Val 
1               5                   


<210> 9
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Ser Tyr Trp Met His 
1               5   


<210> 10
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Lys 
1               5                   10                  15      


Ser 
    


<210> 11
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
1               5                   


<210> 12
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Arg Thr Ser Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn 
1               5                   10                  


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 13
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 14
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 14
Ala Leu Leu Tyr Ser Asn Tyr Trp Val 
1               5                   


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 15
Gly Tyr Thr Phe Thr Ser Tyr 
1               5           


<210> 16
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 16
Tyr Pro Arg Ser Gly Thr 
1               5       


<210> 17
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 17
Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
1               5                   


<210> 18
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 18
Arg Thr Ser Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn 
1               5                   10                  


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 20
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 20
Ala Leu Leu Tyr Ser Asn Tyr Trp Val 
1               5                   


<210> 21
<211> 354
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 21
caggtccaac tgcagcaacc tgggtctgaa ctggtgaggc ctggagcttc agtgaagctg       60

tcctgcaagg cttctggcta cacattcacc agttactgga tgcactgggt gaagcagagg      120

cctgggcaag gccttgagtg gattggaaat atttatcctc gtagtggtac tactaactac      180

gatgggtact tcaagagtaa agccacactg actgtagaca catcctccag cacggcctac      240

atgcagctca gtagcctgac atctgaggac tctgcggtct atttctgtac aagatcggga      300

tatgattacc cttttgttta ctggggccag ggtactctgg tcactgtctc tgca            354


<210> 22
<211> 327
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 22
caggctgttg tgactcagga atctgcactc accacatcac ctggtgaaac agtcacactc       60

acttgtcgca caagtactgg ggctgtttca attagaaact atgccaactg ggtccaagaa      120

aaaccagatc atttattcac tggtctaata ggtggtacca acaaccgagc tccaggtgtt      180

cctgccagat tctcaggctc cctgattgga gacaaggctg ccctcaccat cacaggggca      240

cagcctgagg atgaggcgat atatttctgt gctctattat acagcaatta ttgggtgttc      300

ggtggaggaa ccaaactgac tgtccta                                          327


<210> 23
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 23
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ser Pro Glu Arg Arg Leu Glu Trp Val 
        35                  40                  45              


Ala Glu Ile Ser Ser Gly Gly Ser Tyr Thr Tyr Tyr Pro Asp Thr Val 
    50                  55                  60                  


Thr Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Glu Met Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Val Gly Glu Asp Trp Tyr Phe Asp Val Trp Gly Ala Gly 
            100                 105                 110         


Thr Thr Val Thr Val Ser Ser 
        115                 


<210> 24
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 24
Asp Ile Gln Met Thr Gln Thr Thr Ser Ser Leu Ser Ala Ser Leu Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Ala Ser Gln Asp Ile Ser His Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Asp Gly Ala Val Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ser Thr Ser Arg Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Tyr Ser Leu Thr Ile Ser Asn Leu Glu Gln 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Phe Cys Gln Gln Gly Tyr Thr Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Ser Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210> 25
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 25
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210> 26
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 26
Ile Ser Ser Gly Gly Ser Tyr Thr 
1               5               


<210> 27
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 27
Ala Arg Thr Val Gly Glu Asp Trp Tyr Phe Asp Val 
1               5                   10          


<210> 28
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 28
Gln Asp Ile Ser His Tyr 
1               5       


<210> 29
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 29
Ser Thr Ser 
1           


<210> 30
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 30
Gln Gln Gly Tyr Thr Leu Pro Phe Thr 
1               5                   


<210> 31
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 31
Ser Tyr Ala Met Ser 
1               5   


<210> 32
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 32
Glu Ile Ser Ser Gly Gly Ser Tyr Thr Tyr Tyr Pro Asp Thr Val Thr 
1               5                   10                  15      


Gly 
    


<210> 33
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 33
Thr Val Gly Glu Asp Trp Tyr Phe Asp Val 
1               5                   10  


<210> 34
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 34
Arg Ala Ser Gln Asp Ile Ser His Tyr Leu Asn 
1               5                   10      


<210> 35
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 35
Ser Thr Ser Arg Leu His Ser 
1               5           


<210> 36
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 36
Gln Gln Gly Tyr Thr Leu Pro Phe Thr 
1               5                   


<210> 37
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 37
Gly Phe Thr Phe Ser Ser Tyr 
1               5           


<210> 38
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 38
Ser Ser Gly Gly Ser Tyr 
1               5       


<210> 39
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 39
Thr Val Gly Glu Asp Trp Tyr Phe Asp Val 
1               5                   10  


<210> 40
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 40
Arg Ala Ser Gln Asp Ile Ser His Tyr Leu Asn 
1               5                   10      


<210> 41
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 41
Ser Thr Ser Arg Leu His Ser 
1               5           


<210> 42
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 42
Gln Gln Gly Tyr Thr Leu Pro Phe Thr 
1               5                   


<210> 43
<211> 357
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 43
gaagtgcagc tggtggagtc tgggggaggc ttagtgaagc ctggagggtc cctgaaactc       60

tcctgtgcag cctctggatt cactttcagt agctatgcca tgtcttgggt tcgccagtct      120

ccagagagga ggctggagtg ggtcgcagaa attagtagtg gtggtagtta tacctactat      180

ccagacactg tgacgggccg attcaccatc tccagagaca atgccaagaa caccctgtac      240

ctggaaatga gcagtctgag gtctgaggac acggccatgt attactgtgc aaggacagta      300

ggtgaggact ggtacttcga tgtctggggc gcagggacca cggtcaccgt ctcctca         357


<210> 44
<211> 321
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 44
gatatccaga tgacacagac tacatcctcc ctgtctgcct ctctgggaga cagagtcacc       60

atcagttgca gggcaagtca ggacattagt cattatttaa actggtatca gcagaaacca      120

gatggagctg ttaaactcct gatctactcc acatcaagat tacactcagg agtcccatca      180

aggttcagtg gcagtgggtc tggaacagat tattctctca ccattagcaa cctggagcaa      240

gaagatattg ccacttactt ttgccaacag ggttatacgc ttccattcac gttcggctcg      300

gggacaaaat tggaaataaa a                                                321


<210> 45
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 45
Asp Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Arg Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Glu Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Tyr Ile Ser Ser Gly Ser Ser Thr Ile Tyr Tyr Ala Asp Thr Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Pro Lys Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Met Thr Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ser Tyr Arg Ala Met Asp Tyr Trp Gly Gln Gly Thr Ser 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210> 46
<211> 106
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 46
Gln Ile Val Leu Thr Gln Ser Pro Ala Leu Met Ser Ala Ser Pro Gly 
1               5                   10                  15      


Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Asn Tyr Met 
            20                  25                  30          


Phe Trp Tyr Gln Gln Lys Pro Arg Ser Ser Pro Lys Pro Trp Ile Tyr 
        35                  40                  45              


Leu Thr Ser Asn Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser 
    50                  55                  60                  


Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu 
65                  70                  75                  80  


Asp Ala Ala Thr Tyr Tyr Cys Gln Leu Trp Ser Ser Asn Pro Phe Thr 
                85                  90                  95      


Phe Gly Ser Gly Thr Lys Leu Glu Ile Lys 
            100                 105     


<210> 47
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 47
Gly Phe Thr Phe Ser Ser Phe Gly 
1               5               


<210> 48
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 48
Ile Ser Ser Gly Ser Ser Thr Ile 
1               5               


<210> 49
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 49
Ala Arg Gly Ser Tyr Arg Ala Met Asp Tyr 
1               5                   10  


<210> 50
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 50
Ser Ser Val Asn Tyr 
1               5   


<210> 51
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 51
Leu Thr Ser 
1           


<210> 52
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 52
Gln Leu Trp Ser Ser Asn Pro Phe Thr 
1               5                   


<210> 53
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 53
Ser Phe Gly Met His 
1               5   


<210> 54
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 54
Tyr Ile Ser Ser Gly Ser Ser Thr Ile Tyr Tyr Ala Asp Thr Val Lys 
1               5                   10                  15      


Gly 
    


<210> 55
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 55
Gly Ser Tyr Arg Ala Met Asp Tyr 
1               5               


<210> 56
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 56
Ser Ala Ser Ser Ser Val Asn Tyr Met Phe 
1               5                   10  


<210> 57
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 57
Leu Thr Ser Asn Leu Ala Ser 
1               5           


<210> 58
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 58
Gln Leu Trp Ser Ser Asn Pro Phe Thr 
1               5                   


<210> 59
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 59
Gly Phe Thr Phe Ser Ser Phe 
1               5           


<210> 60
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 60
Ser Ser Gly Ser Ser Thr 
1               5       


<210> 61
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 61
Gly Ser Tyr Arg Ala Met Asp Tyr 
1               5               


<210> 62
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 62
Ser Ala Ser Ser Ser Val Asn Tyr Met Phe 
1               5                   10  


<210> 63
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 63
Leu Thr Ser Asn Leu Ala Ser 
1               5           


<210> 64
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 64
Gln Leu Trp Ser Ser Asn Pro Phe Thr 
1               5                   


<210> 65
<211> 351
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 65
gatgtgcagc tggtggagtc tgggggaggc ttagtgcagc ctggagggtc ccggaaactc       60

tcctgtgcag cctctggatt cactttcagt agctttggaa tgcactgggt tcgtcaggct      120

ccagagaagg ggctggagtg ggtcgcatac attagtagtg gcagtagtac catctactat      180

gcagacacag tgaagggccg attcaccatc tccagagaca atcccaagaa caccctgttc      240

ctgcaaatga ccagtctaag gtctgaggac acggccatgt attactgtgc aagagggagc      300

tacagggcta tggactactg gggtcaagga acctcagtca ccgtctcctc a               351


<210> 66
<211> 318
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 66
caaattgttc tcacccagtc tccagcactc atgtctgcat ctccagggga gaaggtcacc       60

atgacctgca gtgccagctc aagtgtaaat tacatgttct ggtaccagca gaagccaaga      120

tcctccccca aaccctggat ttatctcaca tccaacctgg cttctggagt ccctgctcgc      180

ttcagtggca gtgggtctgg gacctcttac tctctcacaa tcagcagcat ggaggctgaa      240

gatgctgcca cttattactg ccagctgtgg agtagtaacc cattcacgtt cggctcgggg      300

acaaagttgg aaataaaa                                                    318


<210> 67
<211> 125
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 67
Asp Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Arg Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Gly Ile His Trp Val Arg Gln Ala Pro Glu Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Tyr Ile Ser Ser Gly Ser Ser Thr Ile Tyr Tyr Ala Asp Thr Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Pro Lys Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Met Thr Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ser Lys Val Val Ala Lys Ser Arg Gly Tyr Trp Tyr Phe 
            100                 105                 110         


Asp Val Trp Gly Ala Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210> 68
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 68
Asp Val Val Val Thr Gln Thr Pro Leu Phe Leu Pro Val Ser Phe Gly 
1               5                   10                  15      


Asp Gln Val Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Ala Asn Asn 
            20                  25                  30          


Tyr Gly Ile Thr Tyr Leu Ser Trp Tyr Leu His Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Gly Ile Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Thr Ile Lys Pro Glu Asp Leu Gly Met Tyr Tyr Cys Leu Gln Gly 
                85                  90                  95      


Thr His Gln Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210> 69
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 69
Gly Phe Thr Phe Ser Ser Phe Gly 
1               5               


<210> 70
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 70
Ile Ser Ser Gly Ser Ser Thr Ile 
1               5               


<210> 71
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 71
Ala Arg Gly Ser Lys Val Val Ala Lys Ser Arg Gly Tyr Trp Tyr Phe 
1               5                   10                  15      


Asp Val 
        


<210> 72
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 72
Gln Ser Leu Ala Asn Asn Tyr Gly Ile Thr Tyr 
1               5                   10      


<210> 73
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 73
Gly Ile Ser 
1           


<210> 74
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 74
Leu Gln Gly Thr His Gln Pro Trp Thr 
1               5                   


<210> 75
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 75
Ser Phe Gly Ile His 
1               5   


<210> 76
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 76
Tyr Ile Ser Ser Gly Ser Ser Thr Ile Tyr Tyr Ala Asp Thr Val Lys 
1               5                   10                  15      


Gly 
    


<210> 77
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 77
Gly Ser Lys Val Val Ala Lys Ser Arg Gly Tyr Trp Tyr Phe Asp Val 
1               5                   10                  15      


<210> 78
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 78
Arg Ser Ser Gln Ser Leu Ala Asn Asn Tyr Gly Ile Thr Tyr Leu Ser 
1               5                   10                  15      


<210> 79
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 79
Gly Ile Ser Asn Arg Phe Ser 
1               5           


<210> 80
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 80
Leu Gln Gly Thr His Gln Pro Trp Thr 
1               5                   


<210> 81
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 81
Gly Phe Thr Phe Ser Ser Phe 
1               5           


<210> 82
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 82
Ser Ser Gly Ser Ser Thr 
1               5       


<210> 83
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 83
Gly Ser Lys Val Val Ala Lys Ser Arg Gly Tyr Trp Tyr Phe Asp Val 
1               5                   10                  15      


<210> 84
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 84
Arg Ser Ser Gln Ser Leu Ala Asn Asn Tyr Gly Ile Thr Tyr Leu Ser 
1               5                   10                  15      


<210> 85
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 85
Gly Ile Ser Asn Arg Phe Ser 
1               5           


<210> 86
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 86
Leu Gln Gly Thr His Gln Pro Trp Thr 
1               5                   


<210> 87
<211> 375
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 87
gatgtgcagc tggtggagtc tgggggaggc ttagtgcagc ctggagggtc ccggaaactc       60

tcctgtgcag cctctggatt cactttcagt agttttggaa ttcactgggt tcgtcaggct      120

ccagagaagg ggctggagtg ggtcgcatac ataagtagtg gcagtagtac catctactat      180

gcagacacag tgaagggccg attcaccatc tccagagaca atcccaagaa caccctgttc      240

ctgcaaatga ccagtctaag gtctgaggac acggccatgt attactgtgc aagagggtct      300

aaggtagtag ctaagtcaag gggctactgg tacttcgatg tctggggcgc agggaccacg      360

gtcaccgtct cctca                                                       375


<210> 88
<211> 335
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 88
gatgttgtgg tgactcaaac tccactcttc ctgcctgtca gctttggaga tcaagtttct       60

atctcttgca ggtctagtca gagtcttgaa acaattatgg gatcacctat ttgtcttggt      120

acctgcacag gcctggccag tctccccagc tcctcatcta tgggatttcc aacagatttt      180

ctggggtgcc agacaggttc agtggcagtg gttcagggac agatttcaca ctcaagatca      240

gcacaataaa gcctgaggac ttgggaatgt attactgctt acaaggtaca catcagccgt      300

ggacgttcgg tggaggcacc aagctggaaa tcaaa                                 335


<210> 89
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Ala" or "Gly"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 89
Gly Tyr Thr Phe Thr Ser Tyr Trp 
1               5               


<210> 90
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ile"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 90
Tyr Pro Arg Ser Gly Thr Thr 
1               5           


<210> 91
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 91
Gly Thr Asn 
1           


<210> 92
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 92
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr 
1               5                   


<210> 93
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ala" or "Gly"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(5)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 93
Ser Tyr Trp Met His 
1               5   


<210> 94
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Glu" or "Tyr"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Pro" or "Ala"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Asp"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Val"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="Gly"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 94
Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Lys 
1               5                   10                  15      


Ser 
    


<210> 95
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Arg"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Leu"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="His" or "Phe"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 95
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 96
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 96
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr 
1               5                   


<210> 97
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Phe"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 97
Gly Tyr Thr Phe Thr Ser Tyr 
1               5           


<210> 98
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Tyr"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 98
Tyr Pro Arg Ser Gly Thr 
1               5       


<210> 99
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Arg"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Leu"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="His" or "Phe"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 99
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 100
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 100
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr 
1               5                   


<210> 101
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 101
Gly Tyr Thr Phe Thr Ser Tyr Trp Met His 
1               5                   10  


<210> 102
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 102
Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Lys 
1               5                   10                  15      


Ser 
    


<210> 103
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 103
Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
1               5                   10      


<210> 104
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 104
Arg Thr Ser Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn 
1               5                   10                  


<210> 105
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 105
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 106
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 106
Ala Leu Leu Tyr Ser Asn Tyr Trp Val 
1               5                   


<210> 107
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 107
Gly Phe Thr Phe Ser Ser Tyr Ala Met Ser 
1               5                   10  


<210> 108
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 108
Glu Ile Ser Ser Gly Gly Ser Tyr Thr Tyr Tyr Pro Asp Thr Val Thr 
1               5                   10                  15      


Gly 
    


<210> 109
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 109
Ala Arg Thr Val Gly Glu Asp Trp Tyr Phe Asp Val 
1               5                   10          


<210> 110
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 110
Arg Ala Ser Gln Asp Ile Ser His Tyr Leu Asn 
1               5                   10      


<210> 111
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 111
Ser Thr Ser Arg Leu His Ser 
1               5           


<210> 112
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 112
Gln Gln Gly Tyr Thr Leu Pro Phe Thr 
1               5                   


<210> 113
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 113
Gly Phe Thr Phe Ser Ser Phe Gly Met His 
1               5                   10  


<210> 114
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 114
Tyr Ile Ser Ser Gly Ser Ser Thr Ile Tyr Tyr Ala Asp Thr Val Lys 
1               5                   10                  15      


Gly 
    


<210> 115
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 115
Ala Arg Gly Ser Tyr Arg Ala Met Asp Tyr 
1               5                   10  


<210> 116
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 116
Ser Ala Ser Ser Ser Val Asn Tyr Met Phe 
1               5                   10  


<210> 117
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 117
Leu Thr Ser Asn Leu Ala Ser 
1               5           


<210> 118
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 118
Gln Leu Trp Ser Ser Asn Pro Phe Thr 
1               5                   


<210> 119
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 119
Gly Phe Thr Phe Ser Ser Phe Gly Ile His 
1               5                   10  


<210> 120
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 120
Tyr Ile Ser Ser Gly Ser Ser Thr Ile Tyr Tyr Ala Asp Thr Val Lys 
1               5                   10                  15      


Gly 
    


<210> 121
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 121
Ala Arg Gly Ser Lys Val Val Ala Lys Ser Arg Gly Tyr Trp Tyr Phe 
1               5                   10                  15      


Asp Val 
        


<210> 122
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 122
Arg Ser Ser Gln Ser Leu Ala Asn Asn Tyr Gly Ile Thr Tyr Leu Ser 
1               5                   10                  15      


<210> 123
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 123
Gly Ile Ser Asn Arg Phe Ser 
1               5           


<210> 124
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 124
Leu Gln Gly Thr His Gln Pro Trp Thr 
1               5                   


<210> 125
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Ala" or "Gly"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 125
Gly Tyr Thr Phe Thr Ser Tyr Trp Met His 
1               5                   10  


<210> 126
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Glu" or "Tyr"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Pro" or "Ala"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Asp"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Val"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="Lys"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="Gly"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 126
Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Thr 
1               5                   10                  15      


Ser 
    


<210> 127
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Arg"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Leu"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="His" or "Phe"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 127
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 128
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 128
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr 
1               5                   


<210> 129
<211> 2
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 129
Ser Tyr 
1       


<210> 130
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 130
Tyr Pro Arg Ser Gly Thr 
1               5       


<210> 131
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 131
Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
1               5                   


<210> 132
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 132
Thr Gly Ala Val Ser Ile Arg Asn Tyr 
1               5                   


<210> 133
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 133
Gly Thr Asn 
1           


<210> 134
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 134
Ala Leu Leu Tyr Ser Asn Tyr Trp Val 
1               5                   


<210> 135
<211> 2
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 135
Ser Tyr 
1       


<210> 136
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 136
Ser Ser Gly Gly Ser Tyr 
1               5       


<210> 137
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 137
Thr Val Gly Glu Asp Trp Tyr Phe Asp Val 
1               5                   10  


<210> 138
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 138
Gln Asp Ile Ser His Tyr 
1               5       


<210> 139
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 139
Ser Thr Ser 
1           


<210> 140
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 140
Gln Gln Gly Tyr Thr Leu Pro Phe Thr 
1               5                   


<210> 141
<211> 2
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 141
Ser Phe 
1       


<210> 142
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 142
Ser Ser Gly Ser Ser Thr 
1               5       


<210> 143
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 143
Gly Ser Tyr Arg Ala Met Asp Tyr 
1               5               


<210> 144
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 144
Ser Ser Val Asn Tyr 
1               5   


<210> 145
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 145
Leu Thr Ser 
1           


<210> 146
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 146
Gln Leu Trp Ser Ser Asn Pro Phe Thr 
1               5                   


<210> 147
<211> 2
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 147
Ser Phe 
1       


<210> 148
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 148
Ser Ser Gly Ser Ser Thr 
1               5       


<210> 149
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 149
Gly Ser Lys Val Val Ala Lys Ser Arg Gly Tyr Trp Tyr Phe Asp Val 
1               5                   10                  15      


<210> 150
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 150
Gln Ser Leu Ala Asn Asn Tyr Gly Ile Thr Tyr 
1               5                   10      


<210> 151
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 151
Gly Ile Ser 
1           


<210> 152
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 152
Leu Gln Gly Thr His Gln Pro Trp Thr 
1               5                   


<210> 153
<211> 2
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> SITE
<222> (1)..(2)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 153
Ser Tyr 
1       


<210> 154
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Tyr"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 154
Tyr Pro Arg Ser Gly Thr 
1               5       


<210> 155
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 155
Gly Thr Asn 
1           


<210> 156
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 156
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr 
1               5                   


<210> 157
<211> 493
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 157
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Ala Val Val Thr Gln Glu Ser Ala Leu Thr 
            20                  25                  30          


Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys Arg Thr Ser Thr Gly 
        35                  40                  45              


Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val Gln Glu Lys Pro Asp 
    50                  55                  60                  


His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn Asn Arg Ala Pro Gly 
65                  70                  75                  80  


Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly Asp Lys Ala Ala Leu 
                85                  90                  95      


Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala Ile Tyr Phe Cys Ala 
            100                 105                 110         


Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr 
        115                 120                 125             


Val Leu Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
    130                 135                 140                 


Ser Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu Val Arg Pro Gly 
145                 150                 155                 160 


Ala Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser 
                165                 170                 175     


Tyr Trp Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp 
            180                 185                 190         


Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr 
        195                 200                 205             


Phe Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser Ser Ser Thr Ala 
    210                 215                 220                 


Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe 
225                 230                 235                 240 


Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr Trp Gly Gln Gly 
                245                 250                 255     


Thr Leu Val Thr Val Ser Ala Thr Thr Thr Pro Ala Pro Arg Pro Pro 
            260                 265                 270         


Thr Pro Ala Pro Thr Ile Ala Ser Pro Leu Ser Leu Arg Pro Glu Ala 
        275                 280                 285             


Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe 
    290                 295                 300                 


Ala Cys Asp Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys 
305                 310                 315                 320 


Tyr Ser Leu Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val Arg Ser 
                325                 330                 335     


Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg 
            340                 345                 350         


Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg 
        355                 360                 365             


Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp 
    370                 375                 380                 


Ala Pro Ala Tyr Gln Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn 
385                 390                 395                 400 


Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg 
                405                 410                 415     


Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly 
            420                 425                 430         


Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu 
        435                 440                 445             


Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu 
    450                 455                 460                 


Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His 
465                 470                 475                 480 


Met Gln Ala Leu Pro Pro Arg Arg Lys Arg Gly Ser Gly 
                485                 490             


<210> 158
<211> 461
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 158
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Ala Val Val Thr Gln Glu Ser Ala Leu Thr 
            20                  25                  30          


Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys Arg Thr Ser Thr Gly 
        35                  40                  45              


Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val Gln Glu Lys Pro Asp 
    50                  55                  60                  


His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn Asn Arg Ala Pro Gly 
65                  70                  75                  80  


Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly Asp Lys Ala Ala Leu 
                85                  90                  95      


Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala Ile Tyr Phe Cys Ala 
            100                 105                 110         


Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr 
        115                 120                 125             


Val Leu Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
    130                 135                 140                 


Ser Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu Val Arg Pro Gly 
145                 150                 155                 160 


Ala Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser 
                165                 170                 175     


Tyr Trp Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp 
            180                 185                 190         


Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr 
        195                 200                 205             


Phe Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser Ser Ser Thr Ala 
    210                 215                 220                 


Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe 
225                 230                 235                 240 


Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr Trp Gly Gln Gly 
                245                 250                 255     


Thr Leu Val Thr Val Ser Ala Glu Ser Lys Tyr Gly Pro Pro Cys Pro 
            260                 265                 270         


Ser Cys Pro Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys 
        275                 280                 285             


Tyr Ser Leu Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val Arg Ser 
    290                 295                 300                 


Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg 
305                 310                 315                 320 


Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg 
                325                 330                 335     


Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp 
            340                 345                 350         


Ala Pro Ala Tyr Gln Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn 
        355                 360                 365             


Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg 
    370                 375                 380                 


Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly 
385                 390                 395                 400 


Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu 
                405                 410                 415     


Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu 
            420                 425                 430         


Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His 
        435                 440                 445             


Met Gln Ala Leu Pro Pro Arg Arg Lys Arg Gly Ser Gly 
    450                 455                 460     


<210> 159
<211> 678
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 159
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Ala Val Val Thr Gln Glu Ser Ala Leu Thr 
            20                  25                  30          


Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys Arg Thr Ser Thr Gly 
        35                  40                  45              


Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val Gln Glu Lys Pro Asp 
    50                  55                  60                  


His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn Asn Arg Ala Pro Gly 
65                  70                  75                  80  


Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly Asp Lys Ala Ala Leu 
                85                  90                  95      


Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala Ile Tyr Phe Cys Ala 
            100                 105                 110         


Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr 
        115                 120                 125             


Val Leu Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
    130                 135                 140                 


Ser Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu Val Arg Pro Gly 
145                 150                 155                 160 


Ala Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser 
                165                 170                 175     


Tyr Trp Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp 
            180                 185                 190         


Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr 
        195                 200                 205             


Phe Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser Ser Ser Thr Ala 
    210                 215                 220                 


Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe 
225                 230                 235                 240 


Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr Trp Gly Gln Gly 
                245                 250                 255     


Thr Leu Val Thr Val Ser Ala Glu Ser Lys Tyr Gly Pro Pro Cys Pro 
            260                 265                 270         


Pro Cys Pro Ala Pro Pro Val Ala Gly Pro Ser Val Phe Leu Phe Pro 
        275                 280                 285             


Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr 
    290                 295                 300                 


Cys Val Val Val Asp Val Ser Gln Glu Asp Pro Glu Val Gln Phe Asn 
305                 310                 315                 320 


Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg 
                325                 330                 335     


Glu Glu Gln Phe Gln Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val 
            340                 345                 350         


Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser 
        355                 360                 365             


Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr Ile Ser Lys Ala Lys 
    370                 375                 380                 


Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Gln Glu 
385                 390                 395                 400 


Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe 
                405                 410                 415     


Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu 
            420                 425                 430         


Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe 
        435                 440                 445             


Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser Arg Trp Gln Glu Gly 
    450                 455                 460                 


Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr 
465                 470                 475                 480 


Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys Met Phe Trp Val Leu 
                485                 490                 495     


Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu Leu Val Thr Val 
            500                 505                 510         


Ala Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser Arg Leu Leu His 
        515                 520                 525             


Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys 
    530                 535                 540                 


His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser 
545                 550                 555                 560 


Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Gln Gln Gly 
                565                 570                 575     


Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr 
            580                 585                 590         


Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys 
        595                 600                 605             


Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys 
    610                 615                 620                 


Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg 
625                 630                 635                 640 


Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala 
                645                 650                 655     


Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg 
            660                 665                 670         


Arg Lys Arg Gly Ser Gly 
        675             


<210> 160
<211> 493
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 160
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu 
            20                  25                  30          


Val Arg Pro Gly Ala Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr 
        35                  40                  45              


Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Arg Pro Gly Gln 
    50                  55                  60                  


Gly Leu Glu Trp Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn 
65                  70                  75                  80  


Tyr Asp Gly Tyr Phe Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser 
                85                  90                  95      


Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser 
            100                 105                 110         


Ala Val Tyr Phe Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
        115                 120                 125             


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala Gly Gly Gly Gly Ser 
    130                 135                 140                 


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Ala Val Val Thr Gln 
145                 150                 155                 160 


Glu Ser Ala Leu Thr Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys 
                165                 170                 175     


Arg Thr Ser Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val 
            180                 185                 190         


Gln Glu Lys Pro Asp His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn 
        195                 200                 205             


Asn Arg Ala Pro Gly Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly 
    210                 215                 220                 


Asp Lys Ala Ala Leu Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala 
225                 230                 235                 240 


Ile Tyr Phe Cys Ala Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly 
                245                 250                 255     


Gly Thr Lys Leu Thr Val Leu Thr Thr Thr Pro Ala Pro Arg Pro Pro 
            260                 265                 270         


Thr Pro Ala Pro Thr Ile Ala Ser Pro Leu Ser Leu Arg Pro Glu Ala 
        275                 280                 285             


Cys Arg Pro Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe 
    290                 295                 300                 


Ala Cys Asp Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys 
305                 310                 315                 320 


Tyr Ser Leu Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val Arg Ser 
                325                 330                 335     


Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg 
            340                 345                 350         


Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg 
        355                 360                 365             


Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp 
    370                 375                 380                 


Ala Pro Ala Tyr Gln Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn 
385                 390                 395                 400 


Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg 
                405                 410                 415     


Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly 
            420                 425                 430         


Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu 
        435                 440                 445             


Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu 
    450                 455                 460                 


Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His 
465                 470                 475                 480 


Met Gln Ala Leu Pro Pro Arg Arg Lys Arg Gly Ser Gly 
                485                 490             


<210> 161
<211> 461
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 161
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu 
            20                  25                  30          


Val Arg Pro Gly Ala Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr 
        35                  40                  45              


Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Arg Pro Gly Gln 
    50                  55                  60                  


Gly Leu Glu Trp Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn 
65                  70                  75                  80  


Tyr Asp Gly Tyr Phe Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser 
                85                  90                  95      


Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser 
            100                 105                 110         


Ala Val Tyr Phe Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
        115                 120                 125             


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala Gly Gly Gly Gly Ser 
    130                 135                 140                 


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Ala Val Val Thr Gln 
145                 150                 155                 160 


Glu Ser Ala Leu Thr Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys 
                165                 170                 175     


Arg Thr Ser Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val 
            180                 185                 190         


Gln Glu Lys Pro Asp His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn 
        195                 200                 205             


Asn Arg Ala Pro Gly Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly 
    210                 215                 220                 


Asp Lys Ala Ala Leu Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala 
225                 230                 235                 240 


Ile Tyr Phe Cys Ala Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly 
                245                 250                 255     


Gly Thr Lys Leu Thr Val Leu Glu Ser Lys Tyr Gly Pro Pro Cys Pro 
            260                 265                 270         


Ser Cys Pro Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys 
        275                 280                 285             


Tyr Ser Leu Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val Arg Ser 
    290                 295                 300                 


Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg 
305                 310                 315                 320 


Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg 
                325                 330                 335     


Asp Phe Ala Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp 
            340                 345                 350         


Ala Pro Ala Tyr Gln Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn 
        355                 360                 365             


Leu Gly Arg Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg 
    370                 375                 380                 


Asp Pro Glu Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly 
385                 390                 395                 400 


Leu Tyr Asn Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu 
                405                 410                 415     


Ile Gly Met Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu 
            420                 425                 430         


Tyr Gln Gly Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His 
        435                 440                 445             


Met Gln Ala Leu Pro Pro Arg Arg Lys Arg Gly Ser Gly 
    450                 455                 460     


<210> 162
<211> 678
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 162
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu 
            20                  25                  30          


Val Arg Pro Gly Ala Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr 
        35                  40                  45              


Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Arg Pro Gly Gln 
    50                  55                  60                  


Gly Leu Glu Trp Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn 
65                  70                  75                  80  


Tyr Asp Gly Tyr Phe Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser 
                85                  90                  95      


Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser 
            100                 105                 110         


Ala Val Tyr Phe Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
        115                 120                 125             


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala Gly Gly Gly Gly Ser 
    130                 135                 140                 


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Ala Val Val Thr Gln 
145                 150                 155                 160 


Glu Ser Ala Leu Thr Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys 
                165                 170                 175     


Arg Thr Ser Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val 
            180                 185                 190         


Gln Glu Lys Pro Asp His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn 
        195                 200                 205             


Asn Arg Ala Pro Gly Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly 
    210                 215                 220                 


Asp Lys Ala Ala Leu Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala 
225                 230                 235                 240 


Ile Tyr Phe Cys Ala Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly 
                245                 250                 255     


Gly Thr Lys Leu Thr Val Leu Glu Ser Lys Tyr Gly Pro Pro Cys Pro 
            260                 265                 270         


Pro Cys Pro Ala Pro Pro Val Ala Gly Pro Ser Val Phe Leu Phe Pro 
        275                 280                 285             


Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr 
    290                 295                 300                 


Cys Val Val Val Asp Val Ser Gln Glu Asp Pro Glu Val Gln Phe Asn 
305                 310                 315                 320 


Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg 
                325                 330                 335     


Glu Glu Gln Phe Gln Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val 
            340                 345                 350         


Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser 
        355                 360                 365             


Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr Ile Ser Lys Ala Lys 
    370                 375                 380                 


Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Gln Glu 
385                 390                 395                 400 


Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe 
                405                 410                 415     


Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu 
            420                 425                 430         


Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe 
        435                 440                 445             


Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser Arg Trp Gln Glu Gly 
    450                 455                 460                 


Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr 
465                 470                 475                 480 


Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys Met Phe Trp Val Leu 
                485                 490                 495     


Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu Leu Val Thr Val 
            500                 505                 510         


Ala Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser Arg Leu Leu His 
        515                 520                 525             


Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys 
    530                 535                 540                 


His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser 
545                 550                 555                 560 


Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Gln Gln Gly 
                565                 570                 575     


Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr 
            580                 585                 590         


Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys 
        595                 600                 605             


Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys 
    610                 615                 620                 


Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg 
625                 630                 635                 640 


Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala 
                645                 650                 655     


Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg 
            660                 665                 670         


Arg Lys Arg Gly Ser Gly 
        675             


<210> 163
<211> 730
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 163
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Ala Val Val Thr Gln Glu Ser Ala Leu Thr 
            20                  25                  30          


Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys Arg Thr Ser Thr Gly 
        35                  40                  45              


Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val Gln Glu Lys Pro Asp 
    50                  55                  60                  


His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn Asn Arg Ala Pro Gly 
65                  70                  75                  80  


Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly Asp Lys Ala Ala Leu 
                85                  90                  95      


Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala Ile Tyr Phe Cys Ala 
            100                 105                 110         


Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr 
        115                 120                 125             


Val Leu Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln Pro Gly Ser 
    130                 135                 140                 


Glu Leu Val Arg Pro Gly Ala Ser Val Lys Leu Ser Cys Lys Ala Ser 
145                 150                 155                 160 


Gly Tyr Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Arg Pro 
                165                 170                 175     


Gly Gln Gly Leu Glu Trp Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr 
            180                 185                 190         


Thr Asn Tyr Asp Gly Tyr Phe Lys Ser Lys Ala Thr Leu Thr Val Asp 
        195                 200                 205             


Thr Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu 
    210                 215                 220                 


Asp Ser Ala Val Tyr Phe Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe 
225                 230                 235                 240 


Val Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala Gly Gly Gly 
                245                 250                 255     


Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Ala Val Val 
            260                 265                 270         


Thr Gln Glu Ser Ala Leu Thr Thr Ser Pro Gly Glu Thr Val Thr Leu 
        275                 280                 285             


Thr Cys Arg Thr Ser Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn 
    290                 295                 300                 


Trp Val Gln Glu Lys Pro Asp His Leu Phe Thr Gly Leu Ile Gly Gly 
305                 310                 315                 320 


Thr Asn Asn Arg Ala Pro Gly Val Pro Ala Arg Phe Ser Gly Ser Leu 
                325                 330                 335     


Ile Gly Asp Lys Ala Ala Leu Thr Ile Thr Gly Ala Gln Pro Glu Asp 
            340                 345                 350         


Glu Ala Ile Tyr Phe Cys Ala Leu Leu Tyr Ser Asn Tyr Trp Val Phe 
        355                 360                 365             


Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Gly Gly Gly Ser Gln Val 
    370                 375                 380                 


Gln Leu Gln Gln Pro Gly Ser Glu Leu Val Arg Pro Gly Ala Ser Val 
385                 390                 395                 400 


Lys Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr Trp Met 
                405                 410                 415     


His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile Gly Asn 
            420                 425                 430         


Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Lys Ser 
        435                 440                 445             


Lys Ala Thr Leu Thr Val Asp Thr Ser Ser Ser Thr Ala Tyr Met Gln 
    450                 455                 460                 


Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Thr Arg 
465                 470                 475                 480 


Ser Gly Tyr Asp Tyr Pro Phe Val Tyr Trp Gly Gln Gly Thr Leu Val 
                485                 490                 495     


Thr Val Ser Ala Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala 
            500                 505                 510         


Pro Thr Ile Ala Ser Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro 
        515                 520                 525             


Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp 
    530                 535                 540                 


Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu 
545                 550                 555                 560 


Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser 
                565                 570                 575     


Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly 
            580                 585                 590         


Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala 
        595                 600                 605             


Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala 
    610                 615                 620                 


Tyr Gln Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg 
625                 630                 635                 640 


Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu 
                645                 650                 655     


Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn 
            660                 665                 670         


Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met 
        675                 680                 685             


Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly 
    690                 695                 700                 


Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala 
705                 710                 715                 720 


Leu Pro Pro Arg Arg Lys Arg Gly Ser Gly 
                725                 730 


<210> 164
<211> 730
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 164
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gln Val Gln Leu Gln Gln Pro Gly Ser Glu Leu 
            20                  25                  30          


Val Arg Pro Gly Ala Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr 
        35                  40                  45              


Thr Phe Thr Ser Tyr Trp Met His Trp Val Lys Gln Arg Pro Gly Gln 
    50                  55                  60                  


Gly Leu Glu Trp Ile Gly Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn 
65                  70                  75                  80  


Tyr Asp Gly Tyr Phe Lys Ser Lys Ala Thr Leu Thr Val Asp Thr Ser 
                85                  90                  95      


Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser 
            100                 105                 110         


Ala Val Tyr Phe Cys Thr Arg Ser Gly Tyr Asp Tyr Pro Phe Val Tyr 
        115                 120                 125             


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala Gly Gly Gly Gly Ser 
    130                 135                 140                 


Gln Ala Val Val Thr Gln Glu Ser Ala Leu Thr Thr Ser Pro Gly Glu 
145                 150                 155                 160 


Thr Val Thr Leu Thr Cys Arg Thr Ser Thr Gly Ala Val Ser Ile Arg 
                165                 170                 175     


Asn Tyr Ala Asn Trp Val Gln Glu Lys Pro Asp His Leu Phe Thr Gly 
            180                 185                 190         


Leu Ile Gly Gly Thr Asn Asn Arg Ala Pro Gly Val Pro Ala Arg Phe 
        195                 200                 205             


Ser Gly Ser Leu Ile Gly Asp Lys Ala Ala Leu Thr Ile Thr Gly Ala 
    210                 215                 220                 


Gln Pro Glu Asp Glu Ala Ile Tyr Phe Cys Ala Leu Leu Tyr Ser Asn 
225                 230                 235                 240 


Tyr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Gly Gly 
                245                 250                 255     


Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu 
            260                 265                 270         


Gln Gln Pro Gly Ser Glu Leu Val Arg Pro Gly Ala Ser Val Lys Leu 
        275                 280                 285             


Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr Trp Met His Trp 
    290                 295                 300                 


Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile Gly Asn Ile Tyr 
305                 310                 315                 320 


Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Lys Ser Lys Ala 
                325                 330                 335     


Thr Leu Thr Val Asp Thr Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser 
            340                 345                 350         


Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Thr Arg Ser Gly 
        355                 360                 365             


Tyr Asp Tyr Pro Phe Val Tyr Trp Gly Gln Gly Thr Leu Val Thr Val 
    370                 375                 380                 


Ser Ala Gly Gly Gly Gly Ser Gln Ala Val Val Thr Gln Glu Ser Ala 
385                 390                 395                 400 


Leu Thr Thr Ser Pro Gly Glu Thr Val Thr Leu Thr Cys Arg Thr Ser 
                405                 410                 415     


Thr Gly Ala Val Ser Ile Arg Asn Tyr Ala Asn Trp Val Gln Glu Lys 
            420                 425                 430         


Pro Asp His Leu Phe Thr Gly Leu Ile Gly Gly Thr Asn Asn Arg Ala 
        435                 440                 445             


Pro Gly Val Pro Ala Arg Phe Ser Gly Ser Leu Ile Gly Asp Lys Ala 
    450                 455                 460                 


Ala Leu Thr Ile Thr Gly Ala Gln Pro Glu Asp Glu Ala Ile Tyr Phe 
465                 470                 475                 480 


Cys Ala Leu Leu Tyr Ser Asn Tyr Trp Val Phe Gly Gly Gly Thr Lys 
                485                 490                 495     


Leu Thr Val Leu Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala 
            500                 505                 510         


Pro Thr Ile Ala Ser Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro 
        515                 520                 525             


Ala Ala Gly Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp 
    530                 535                 540                 


Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu 
545                 550                 555                 560 


Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser 
                565                 570                 575     


Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly 
            580                 585                 590         


Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala 
        595                 600                 605             


Ala Tyr Arg Ser Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala 
    610                 615                 620                 


Tyr Gln Gln Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg 
625                 630                 635                 640 


Arg Glu Glu Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu 
                645                 650                 655     


Met Gly Gly Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn 
            660                 665                 670         


Glu Leu Gln Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met 
        675                 680                 685             


Lys Gly Glu Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly 
    690                 695                 700                 


Leu Ser Thr Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala 
705                 710                 715                 720 


Leu Pro Pro Arg Arg Lys Arg Gly Ser Gly 
                725                 730 


<210> 165
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Glycosylated Thr

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Glycosylated Ser

<400> 165
Gly Tyr Arg Gln Xaa Pro Lys Glu Asp Ser His Xaa Thr Thr Gly Thr 
1               5                   10                  15      


Ala Ala Ala 
            


<210> 166
<211> 127
<212> PRT
<213> Homo sapiens

<400> 166
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly 
1               5                   10                  15      


Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met 
            20                  25                  30          


Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His 
        35                  40                  45              


Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val 
    50                  55                  60                  


His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr 
65                  70                  75                  80  


Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly 
                85                  90                  95      


Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile 
            100                 105                 110         


Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln 
        115                 120                 125         


<210> 167
<211> 2955
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 167
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggccg tggtgaccca ggagagcgcc ctgaccacca gccccggcga gaccgtgacc      120

ctgacctgca ggaccagcac cggcgccgtg agcatcagga actacgccaa ctgggtgcag      180

gagaagcccg accacctgtt caccggcctg atcggcggca ccaacaacag ggcccccggc      240

gtgcccgcca ggttcagcgg cagcctgatc ggcgacaagg ccgccctgac catcaccggc      300

gcccagcccg aggacgaggc catctacttc tgcgccctgc tgtacagcaa ctactgggtg      360

ttcggcggcg gcaccaagct gaccgtgctg ggcggcggcg gcagccaggt gcagctgcag      420

cagcccggca gcgagctggt gaggcccggc gccagcgtga agctgagctg caaggccagc      480

ggctacacct tcaccagcta ctggatgcac tgggtgaagc agaggcccgg ccagggcctg      540

gagtggatcg gcaacatcta ccccaggagc ggcaccacca actacgacgg ctacttcaag      600

agcaaggcca ccctgaccgt ggacaccagc agcagcaccg cctacatgca gctgagcagc      660

ctgaccagcg aggacagcgc cgtgtacttc tgcaccagga gcggctacga ctaccccttc      720

gtgtactggg gccagggcac cctggtgacc gtgagcgccg gcggcggcgg cagcggcggc      780

ggcggcagcg gcggcggcgg cagccaggcc gtggtgaccc aggagagcgc cctgaccacc      840

agccccggcg agaccgtgac cctgacctgc aggaccagca ccggcgccgt gagcatcagg      900

aactacgcca actgggtgca ggagaagccc gaccacctgt tcaccggcct gatcggcggc      960

accaacaaca gggcccccgg cgtgcccgcc aggttcagcg gcagcctgat cggcgacaag     1020

gccgccctga ccatcaccgg cgcccagccc gaggacgagg ccatctactt ctgcgccctg     1080

ctgtacagca actactgggt gttcggcggc ggcaccaagc tgaccgtgct gggcggcggc     1140

ggcagccagg tgcagctgca gcagcccggc agcgagctgg tgaggcccgg cgccagcgtg     1200

aagctgagct gcaaggccag cggctacacc ttcaccagct actggatgca ctgggtgaag     1260

cagaggcccg gccagggcct ggagtggatc ggcaacatct accccaggag cggcaccacc     1320

aactacgacg gctacttcaa gagcaaggcc accctgaccg tggacaccag cagcagcacc     1380

gcctacatgc agctgagcag cctgaccagc gaggacagcg ccgtgtactt ctgcaccagg     1440

agcggctacg actacccctt cgtgtactgg ggccagggca ccctggtgac cgtgagcgcc     1500

accaccaccc ccgcccccag gccccccacc cccgccccca ccatcgccag ccccctgagc     1560

ctgaggcccg aggcctgcag gcccgccgcc ggcggcgccg tgcacaccag gggcctggac     1620

ttcgcctgcg acttctgggt gctggtggtg gtgggcggcg tgctggcctg ctacagcctg     1680

ctggtgaccg tggccttcat catcttctgg gtgaggagca agaggagcag gctgctgcac     1740

agcgactaca tgaacatgac ccccaggagg cccggcccca ccaggaagca ctaccagccc     1800

tacgcccccc ccagggactt cgccgcctac aggagcaggg tgaagttcag caggagcgcc     1860

gacgcccccg cctaccagca gggccagaac cagctgtaca acgagctgaa cctgggcagg     1920

agggaggagt acgacgtgct ggacaagagg aggggcaggg accccgagat gggcggcaag     1980

cccaggagga agaaccccca ggagggcctg tacaacgagc tgcagaagga caagatggcc     2040

gaggcctaca gcgagatcgg catgaagggc gagaggagga ggggcaaggg ccacgacggc     2100

ctgtaccagg gcctgagcac cgccaccaag gacacctacg acgccctgca catgcaggcc     2160

ctgcccccca ggagaaagag aggaagcgga gagggcagag gaagtctgct aacatgcggt     2220

gacgtcgagg agaatcctgg acctatggtg agcaagggcg aggaggataa catggccatc     2280

atcaaggagt tcatgcgctt caaggtgcac atggagggct ccgtgaacgg ccacgagttc     2340

gagatcgagg gcgagggcga gggccgcccc tacgagggca cccagaccgc caagctgaag     2400

gtgaccaagg gtggccccct gcccttcgcc tgggacatcc tgtcccctca gttcatgtac     2460

ggctccaagg cctacgtgaa gcaccccgcc gacatccccg actacttgaa gctgtccttc     2520

cccgagggct tcaagtggga gcgcgtgatg aacttcgagg acggcggcgt ggtgaccgtg     2580

acccaggact cctccctgca ggacggcgag ttcatctaca aggtgaagct gcgcggcacc     2640

aacttcccct ccgacggccc cgtaatgcag aagaagacca tgggctggga ggcctcctcc     2700

gagcggatgt accccgagga cggcgccctg aagggcgaga tcaagcagag gctgaagctg     2760

aaggacggcg gccactacga cgctgaggtc aagaccacct acaaggccaa gaagcccgtg     2820

cagctgcccg gcgcctacaa cgtcaacatc aagttggaca tcacctccca caacgaggac     2880

tacaccatcg tggaacagta cgaacgcgcc gagggccgcc actccaccgg cggcatggac     2940

gagctgtaca agtag                                                      2955


<210> 168
<211> 2148
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 168
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggccg tggtgaccca ggagagcgcc ctgaccacca gccccggcga gaccgtgacc      120

ctgacctgca ggaccagcac cggcgccgtg agcatcagga actacgccaa ctgggtgcag      180

gagaagcccg accacctgtt caccggcctg atcggcggca ccaacaacag ggcccccggc      240

gtgcccgcca ggttcagcgg cagcctgatc ggcgacaagg ccgccctgac catcaccggc      300

gcccagcccg aggacgaggc catctacttc tgcgccctgc tgtacagcaa ctactgggtg      360

ttcggcggcg gcaccaagct gaccgtgctg ggcggcggcg gcagcggcgg cggcggcagc      420

ggcggcggcg gcagccaggt gcagctgcag cagcccggca gcgagctggt gaggcccggc      480

gccagcgtga agctgagctg caaggccagc ggctacacct tcaccagcta ctggatgcac      540

tgggtgaagc agaggcccgg ccagggcctg gagtggatcg gcaacatcta ccccaggagc      600

ggcaccacca actacgacgg ctacttcaag agcaaggcca ccctgaccgt ggacaccagc      660

agcagcaccg cctacatgca gctgagcagc ctgaccagcg aggacagcgc cgtgtacttc      720

tgcaccagga gcggctacga ctaccccttc gtgtactggg gccagggcac cctggtgacc      780

gtgagcgccg agagcaagta cggccccccc tgccccagct gccccttctg ggtgctggtg      840

gtggtgggcg gcgtgctggc ctgctacagc ctgctggtga ccgtggcctt catcatcttc      900

tgggtgagga gcaagaggag caggctgctg cacagcgact acatgaacat gacccccagg      960

aggcccggcc ccaccaggaa gcactaccag ccctacgccc cccccaggga cttcgccgcc     1020

tacaggagca gggtgaagtt cagcaggagc gccgacgccc ccgcctacca gcagggccag     1080

aaccagctgt acaacgagct gaacctgggc aggagggagg agtacgacgt gctggacaag     1140

aggaggggca gggaccccga gatgggcggc aagcccagga ggaagaaccc ccaggagggc     1200

ctgtacaacg agctgcagaa ggacaagatg gccgaggcct acagcgagat cggcatgaag     1260

ggcgagagga ggaggggcaa gggccacgac ggcctgtacc agggcctgag caccgccacc     1320

aaggacacct acgacgccct gcacatgcag gccctgcccc ccaggagaaa gagaggaagc     1380

ggagagggca gaggaagtct gctaacatgc ggtgacgtcg aggagaatcc tggacctatg     1440

gtgagcaagg gcgaggagga taacatggcc atcatcaagg agttcatgcg cttcaaggtg     1500

cacatggagg gctccgtgaa cggccacgag ttcgagatcg agggcgaggg cgagggccgc     1560

ccctacgagg gcacccagac cgccaagctg aaggtgacca agggtggccc cctgcccttc     1620

gcctgggaca tcctgtcccc tcagttcatg tacggctcca aggcctacgt gaagcacccc     1680

gccgacatcc ccgactactt gaagctgtcc ttccccgagg gcttcaagtg ggagcgcgtg     1740

atgaacttcg aggacggcgg cgtggtgacc gtgacccagg actcctccct gcaggacggc     1800

gagttcatct acaaggtgaa gctgcgcggc accaacttcc cctccgacgg ccccgtaatg     1860

cagaagaaga ccatgggctg ggaggcctcc tccgagcgga tgtaccccga ggacggcgcc     1920

ctgaagggcg agatcaagca gaggctgaag ctgaaggacg gcggccacta cgacgctgag     1980

gtcaagacca cctacaaggc caagaagccc gtgcagctgc ccggcgccta caacgtcaac     2040

atcaagttgg acatcacctc ccacaacgag gactacacca tcgtggaaca gtacgaacgc     2100

gccgagggcc gccactccac cggcggcatg gacgagctgt acaagtag                  2148


<210> 169
<211> 2799
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 169
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggccg tggtgaccca ggagagcgcc ctgaccacca gccccggcga gaccgtgacc      120

ctgacctgca ggaccagcac cggcgccgtg agcatcagga actacgccaa ctgggtgcag      180

gagaagcccg accacctgtt caccggcctg atcggcggca ccaacaacag ggcccccggc      240

gtgcccgcca ggttcagcgg cagcctgatc ggcgacaagg ccgccctgac catcaccggc      300

gcccagcccg aggacgaggc catctacttc tgcgccctgc tgtacagcaa ctactgggtg      360

ttcggcggcg gcaccaagct gaccgtgctg ggcggcggcg gcagcggcgg cggcggcagc      420

ggcggcggcg gcagccaggt gcagctgcag cagcccggca gcgagctggt gaggcccggc      480

gccagcgtga agctgagctg caaggccagc ggctacacct tcaccagcta ctggatgcac      540

tgggtgaagc agaggcccgg ccagggcctg gagtggatcg gcaacatcta ccccaggagc      600

ggcaccacca actacgacgg ctacttcaag agcaaggcca ccctgaccgt ggacaccagc      660

agcagcaccg cctacatgca gctgagcagc ctgaccagcg aggacagcgc cgtgtacttc      720

tgcaccagga gcggctacga ctaccccttc gtgtactggg gccagggcac cctggtgacc      780

gtgagcgccg agagcaagta cggccccccc tgccccccct gccccgcccc ccccgtggcc      840

ggccccagcg tgttcctgtt cccccccaag cccaaggaca ccctgatgat cagcaggacc      900

cccgaggtga cctgcgtggt ggtggacgtg agccaggagg accccgaggt gcagttcaac      960

tggtacgtgg acggcgtgga ggtgcacaac gccaagacca agcccaggga ggagcagttc     1020

cagagcacct acagggtggt gagcgtgctg accgtgctgc accaggactg gctgaacggc     1080

aaggagtaca agtgcaaggt gagcaacaag ggcctgccca gcagcatcga gaagaccatc     1140

agcaaggcca agggccagcc cagggagccc caggtgtaca ccctgccccc cagccaggag     1200

gagatgacca agaaccaggt gagcctgacc tgcctggtga agggcttcta ccccagcgac     1260

atcgccgtgg agtgggagag caacggccag cccgagaaca actacaagac cacccccccc     1320

gtgctggaca gcgacggcag cttcttcctg tacagcaggc tgaccgtgga caagagcagg     1380

tggcaggagg gcaacgtgtt cagctgcagc gtgatgcacg aggccctgca caaccactac     1440

acccagaaga gcctgagcct gagcctgggc aagatgttct gggtgctggt ggtggtgggc     1500

ggcgtgctgg cctgctacag cctgctggtg accgtggcct tcatcatctt ctgggtgagg     1560

agcaagagga gcaggctgct gcacagcgac tacatgaaca tgacccccag gaggcccggc     1620

cccaccagga agcactacca gccctacgcc ccccccaggg acttcgccgc ctacaggagc     1680

agggtgaagt tcagcaggag cgccgacgcc cccgcctacc agcagggcca gaaccagctg     1740

tacaacgagc tgaacctggg caggagggag gagtacgacg tgctggacaa gaggaggggc     1800

agggaccccg agatgggcgg caagcccagg aggaagaacc cccaggaggg cctgtacaac     1860

gagctgcaga aggacaagat ggccgaggcc tacagcgaga tcggcatgaa gggcgagagg     1920

aggaggggca agggccacga cggcctgtac cagggcctga gcaccgccac caaggacacc     1980

tacgacgccc tgcacatgca ggccctgccc cccaggagaa agagaggaag cggagagggc     2040

agaggaagtc tgctaacatg cggtgacgtc gaggagaatc ctggacctat ggtgagcaag     2100

ggcgaggagg ataacatggc catcatcaag gagttcatgc gcttcaaggt gcacatggag     2160

ggctccgtga acggccacga gttcgagatc gagggcgagg gcgagggccg cccctacgag     2220

ggcacccaga ccgccaagct gaaggtgacc aagggtggcc ccctgccctt cgcctgggac     2280

atcctgtccc ctcagttcat gtacggctcc aaggcctacg tgaagcaccc cgccgacatc     2340

cccgactact tgaagctgtc cttccccgag ggcttcaagt gggagcgcgt gatgaacttc     2400

gaggacggcg gcgtggtgac cgtgacccag gactcctccc tgcaggacgg cgagttcatc     2460

tacaaggtga agctgcgcgg caccaacttc ccctccgacg gccccgtaat gcagaagaag     2520

accatgggct gggaggcctc ctccgagcgg atgtaccccg aggacggcgc cctgaagggc     2580

gagatcaagc agaggctgaa gctgaaggac ggcggccact acgacgctga ggtcaagacc     2640

acctacaagg ccaagaagcc cgtgcagctg cccggcgcct acaacgtcaa catcaagttg     2700

gacatcacct cccacaacga ggactacacc atcgtggaac agtacgaacg cgccgagggc     2760

cgccactcca ccggcggcat ggacgagctg tacaagtag                            2799


<210> 170
<211> 2244
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 170
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggtgc agctgcagca gcccggcagc gagctggtga ggcccggcgc cagcgtgaag      120

ctgagctgca aggccagcgg ctacaccttc accagctact ggatgcactg ggtgaagcag      180

aggcccggcc agggcctgga gtggatcggc aacatctacc ccaggagcgg caccaccaac      240

tacgacggct acttcaagag caaggccacc ctgaccgtgg acaccagcag cagcaccgcc      300

tacatgcagc tgagcagcct gaccagcgag gacagcgccg tgtacttctg caccaggagc      360

ggctacgact accccttcgt gtactggggc cagggcaccc tggtgaccgt gagcgccggc      420

ggcggcggca gcggcggcgg cggcagcggc ggcggcggca gccaggccgt ggtgacccag      480

gagagcgccc tgaccaccag ccccggcgag accgtgaccc tgacctgcag gaccagcacc      540

ggcgccgtga gcatcaggaa ctacgccaac tgggtgcagg agaagcccga ccacctgttc      600

accggcctga tcggcggcac caacaacagg gcccccggcg tgcccgccag gttcagcggc      660

agcctgatcg gcgacaaggc cgccctgacc atcaccggcg cccagcccga ggacgaggcc      720

atctacttct gcgccctgct gtacagcaac tactgggtgt tcggcggcgg caccaagctg      780

accgtgctga ccaccacccc cgcccccagg ccccccaccc ccgcccccac catcgccagc      840

cccctgagcc tgaggcccga ggcctgcagg cccgccgccg gcggcgccgt gcacaccagg      900

ggcctggact tcgcctgcga cttctgggtg ctggtggtgg tgggcggcgt gctggcctgc      960

tacagcctgc tggtgaccgt ggccttcatc atcttctggg tgaggagcaa gaggagcagg     1020

ctgctgcaca gcgactacat gaacatgacc cccaggaggc ccggccccac caggaagcac     1080

taccagccct acgccccccc cagggacttc gccgcctaca ggagcagggt gaagttcagc     1140

aggagcgccg acgcccccgc ctaccagcag ggccagaacc agctgtacaa cgagctgaac     1200

ctgggcagga gggaggagta cgacgtgctg gacaagagga ggggcaggga ccccgagatg     1260

ggcggcaagc ccaggaggaa gaacccccag gagggcctgt acaacgagct gcagaaggac     1320

aagatggccg aggcctacag cgagatcggc atgaagggcg agaggaggag gggcaagggc     1380

cacgacggcc tgtaccaggg cctgagcacc gccaccaagg acacctacga cgccctgcac     1440

atgcaggccc tgccccccag gagaaagaga ggaagcggag agggcagagg aagtctgcta     1500

acatgcggtg acgtcgagga gaatcctgga cctatggtga gcaagggcga ggaggataac     1560

atggccatca tcaaggagtt catgcgcttc aaggtgcaca tggagggctc cgtgaacggc     1620

cacgagttcg agatcgaggg cgagggcgag ggccgcccct acgagggcac ccagaccgcc     1680

aagctgaagg tgaccaaggg tggccccctg cccttcgcct gggacatcct gtcccctcag     1740

ttcatgtacg gctccaaggc ctacgtgaag caccccgccg acatccccga ctacttgaag     1800

ctgtccttcc ccgagggctt caagtgggag cgcgtgatga acttcgagga cggcggcgtg     1860

gtgaccgtga cccaggactc ctccctgcag gacggcgagt tcatctacaa ggtgaagctg     1920

cgcggcacca acttcccctc cgacggcccc gtaatgcaga agaagaccat gggctgggag     1980

gcctcctccg agcggatgta ccccgaggac ggcgccctga agggcgagat caagcagagg     2040

ctgaagctga aggacggcgg ccactacgac gctgaggtca agaccaccta caaggccaag     2100

aagcccgtgc agctgcccgg cgcctacaac gtcaacatca agttggacat cacctcccac     2160

aacgaggact acaccatcgt ggaacagtac gaacgcgccg agggccgcca ctccaccggc     2220

ggcatggacg agctgtacaa gtag                                            2244


<210> 171
<211> 2148
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 171
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggtgc agctgcagca gcccggcagc gagctggtga ggcccggcgc cagcgtgaag      120

ctgagctgca aggccagcgg ctacaccttc accagctact ggatgcactg ggtgaagcag      180

aggcccggcc agggcctgga gtggatcggc aacatctacc ccaggagcgg caccaccaac      240

tacgacggct acttcaagag caaggccacc ctgaccgtgg acaccagcag cagcaccgcc      300

tacatgcagc tgagcagcct gaccagcgag gacagcgccg tgtacttctg caccaggagc      360

ggctacgact accccttcgt gtactggggc cagggcaccc tggtgaccgt gagcgccggc      420

ggcggcggca gcggcggcgg cggcagcggc ggcggcggca gccaggccgt ggtgacccag      480

gagagcgccc tgaccaccag ccccggcgag accgtgaccc tgacctgcag gaccagcacc      540

ggcgccgtga gcatcaggaa ctacgccaac tgggtgcagg agaagcccga ccacctgttc      600

accggcctga tcggcggcac caacaacagg gcccccggcg tgcccgccag gttcagcggc      660

agcctgatcg gcgacaaggc cgccctgacc atcaccggcg cccagcccga ggacgaggcc      720

atctacttct gcgccctgct gtacagcaac tactgggtgt tcggcggcgg caccaagctg      780

accgtgctgg agagcaagta cggccccccc tgccccagct gccccttctg ggtgctggtg      840

gtggtgggcg gcgtgctggc ctgctacagc ctgctggtga ccgtggcctt catcatcttc      900

tgggtgagga gcaagaggag caggctgctg cacagcgact acatgaacat gacccccagg      960

aggcccggcc ccaccaggaa gcactaccag ccctacgccc cccccaggga cttcgccgcc     1020

tacaggagca gggtgaagtt cagcaggagc gccgacgccc ccgcctacca gcagggccag     1080

aaccagctgt acaacgagct gaacctgggc aggagggagg agtacgacgt gctggacaag     1140

aggaggggca gggaccccga gatgggcggc aagcccagga ggaagaaccc ccaggagggc     1200

ctgtacaacg agctgcagaa ggacaagatg gccgaggcct acagcgagat cggcatgaag     1260

ggcgagagga ggaggggcaa gggccacgac ggcctgtacc agggcctgag caccgccacc     1320

aaggacacct acgacgccct gcacatgcag gccctgcccc ccaggagaaa gagaggaagc     1380

ggagagggca gaggaagtct gctaacatgc ggtgacgtcg aggagaatcc tggacctatg     1440

gtgagcaagg gcgaggagga taacatggcc atcatcaagg agttcatgcg cttcaaggtg     1500

cacatggagg gctccgtgaa cggccacgag ttcgagatcg agggcgaggg cgagggccgc     1560

ccctacgagg gcacccagac cgccaagctg aaggtgacca agggtggccc cctgcccttc     1620

gcctgggaca tcctgtcccc tcagttcatg tacggctcca aggcctacgt gaagcacccc     1680

gccgacatcc ccgactactt gaagctgtcc ttccccgagg gcttcaagtg ggagcgcgtg     1740

atgaacttcg aggacggcgg cgtggtgacc gtgacccagg actcctccct gcaggacggc     1800

gagttcatct acaaggtgaa gctgcgcggc accaacttcc cctccgacgg ccccgtaatg     1860

cagaagaaga ccatgggctg ggaggcctcc tccgagcgga tgtaccccga ggacggcgcc     1920

ctgaagggcg agatcaagca gaggctgaag ctgaaggacg gcggccacta cgacgctgag     1980

gtcaagacca cctacaaggc caagaagccc gtgcagctgc ccggcgccta caacgtcaac     2040

atcaagttgg acatcacctc ccacaacgag gactacacca tcgtggaaca gtacgaacgc     2100

gccgagggcc gccactccac cggcggcatg gacgagctgt acaagtag                  2148


<210> 172
<211> 2799
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 172
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggtgc agctgcagca gcccggcagc gagctggtga ggcccggcgc cagcgtgaag      120

ctgagctgca aggccagcgg ctacaccttc accagctact ggatgcactg ggtgaagcag      180

aggcccggcc agggcctgga gtggatcggc aacatctacc ccaggagcgg caccaccaac      240

tacgacggct acttcaagag caaggccacc ctgaccgtgg acaccagcag cagcaccgcc      300

tacatgcagc tgagcagcct gaccagcgag gacagcgccg tgtacttctg caccaggagc      360

ggctacgact accccttcgt gtactggggc cagggcaccc tggtgaccgt gagcgccggc      420

ggcggcggca gcggcggcgg cggcagcggc ggcggcggca gccaggccgt ggtgacccag      480

gagagcgccc tgaccaccag ccccggcgag accgtgaccc tgacctgcag gaccagcacc      540

ggcgccgtga gcatcaggaa ctacgccaac tgggtgcagg agaagcccga ccacctgttc      600

accggcctga tcggcggcac caacaacagg gcccccggcg tgcccgccag gttcagcggc      660

agcctgatcg gcgacaaggc cgccctgacc atcaccggcg cccagcccga ggacgaggcc      720

atctacttct gcgccctgct gtacagcaac tactgggtgt tcggcggcgg caccaagctg      780

accgtgctgg agagcaagta cggccccccc tgccccccct gccccgcccc ccccgtggcc      840

ggccccagcg tgttcctgtt cccccccaag cccaaggaca ccctgatgat cagcaggacc      900

cccgaggtga cctgcgtggt ggtggacgtg agccaggagg accccgaggt gcagttcaac      960

tggtacgtgg acggcgtgga ggtgcacaac gccaagacca agcccaggga ggagcagttc     1020

cagagcacct acagggtggt gagcgtgctg accgtgctgc accaggactg gctgaacggc     1080

aaggagtaca agtgcaaggt gagcaacaag ggcctgccca gcagcatcga gaagaccatc     1140

agcaaggcca agggccagcc cagggagccc caggtgtaca ccctgccccc cagccaggag     1200

gagatgacca agaaccaggt gagcctgacc tgcctggtga agggcttcta ccccagcgac     1260

atcgccgtgg agtgggagag caacggccag cccgagaaca actacaagac cacccccccc     1320

gtgctggaca gcgacggcag cttcttcctg tacagcaggc tgaccgtgga caagagcagg     1380

tggcaggagg gcaacgtgtt cagctgcagc gtgatgcacg aggccctgca caaccactac     1440

acccagaaga gcctgagcct gagcctgggc aagatgttct gggtgctggt ggtggtgggc     1500

ggcgtgctgg cctgctacag cctgctggtg accgtggcct tcatcatctt ctgggtgagg     1560

agcaagagga gcaggctgct gcacagcgac tacatgaaca tgacccccag gaggcccggc     1620

cccaccagga agcactacca gccctacgcc ccccccaggg acttcgccgc ctacaggagc     1680

agggtgaagt tcagcaggag cgccgacgcc cccgcctacc agcagggcca gaaccagctg     1740

tacaacgagc tgaacctggg caggagggag gagtacgacg tgctggacaa gaggaggggc     1800

agggaccccg agatgggcgg caagcccagg aggaagaacc cccaggaggg cctgtacaac     1860

gagctgcaga aggacaagat ggccgaggcc tacagcgaga tcggcatgaa gggcgagagg     1920

aggaggggca agggccacga cggcctgtac cagggcctga gcaccgccac caaggacacc     1980

tacgacgccc tgcacatgca ggccctgccc cccaggagaa agagaggaag cggagagggc     2040

agaggaagtc tgctaacatg cggtgacgtc gaggagaatc ctggacctat ggtgagcaag     2100

ggcgaggagg ataacatggc catcatcaag gagttcatgc gcttcaaggt gcacatggag     2160

ggctccgtga acggccacga gttcgagatc gagggcgagg gcgagggccg cccctacgag     2220

ggcacccaga ccgccaagct gaaggtgacc aagggtggcc ccctgccctt cgcctgggac     2280

atcctgtccc ctcagttcat gtacggctcc aaggcctacg tgaagcaccc cgccgacatc     2340

cccgactact tgaagctgtc cttccccgag ggcttcaagt gggagcgcgt gatgaacttc     2400

gaggacggcg gcgtggtgac cgtgacccag gactcctccc tgcaggacgg cgagttcatc     2460

tacaaggtga agctgcgcgg caccaacttc ccctccgacg gccccgtaat gcagaagaag     2520

accatgggct gggaggcctc ctccgagcgg atgtaccccg aggacggcgc cctgaagggc     2580

gagatcaagc agaggctgaa gctgaaggac ggcggccact acgacgctga ggtcaagacc     2640

acctacaagg ccaagaagcc cgtgcagctg cccggcgcct acaacgtcaa catcaagttg     2700

gacatcacct cccacaacga ggactacacc atcgtggaac agtacgaacg cgccgagggc     2760

cgccactcca ccggcggcat ggacgagctg tacaagtag                            2799


<210> 173
<211> 2955
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 173
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggccg tggtgaccca ggagagcgcc ctgaccacca gccccggcga gaccgtgacc      120

ctgacctgca ggaccagcac cggcgccgtg agcatcagga actacgccaa ctgggtgcag      180

gagaagcccg accacctgtt caccggcctg atcggcggca ccaacaacag ggcccccggc      240

gtgcccgcca ggttcagcgg cagcctgatc ggcgacaagg ccgccctgac catcaccggc      300

gcccagcccg aggacgaggc catctacttc tgcgccctgc tgtacagcaa ctactgggtg      360

ttcggcggcg gcaccaagct gaccgtgctg ggcggcggcg gcagccaggt gcagctgcag      420

cagcccggca gcgagctggt gaggcccggc gccagcgtga agctgagctg caaggccagc      480

ggctacacct tcaccagcta ctggatgcac tgggtgaagc agaggcccgg ccagggcctg      540

gagtggatcg gcaacatcta ccccaggagc ggcaccacca actacgacgg ctacttcaag      600

agcaaggcca ccctgaccgt ggacaccagc agcagcaccg cctacatgca gctgagcagc      660

ctgaccagcg aggacagcgc cgtgtacttc tgcaccagga gcggctacga ctaccccttc      720

gtgtactggg gccagggcac cctggtgacc gtgagcgccg gcggcggcgg cagcggcggc      780

ggcggcagcg gcggcggcgg cagccaggcc gtggtgaccc aggagagcgc cctgaccacc      840

agccccggcg agaccgtgac cctgacctgc aggaccagca ccggcgccgt gagcatcagg      900

aactacgcca actgggtgca ggagaagccc gaccacctgt tcaccggcct gatcggcggc      960

accaacaaca gggcccccgg cgtgcccgcc aggttcagcg gcagcctgat cggcgacaag     1020

gccgccctga ccatcaccgg cgcccagccc gaggacgagg ccatctactt ctgcgccctg     1080

ctgtacagca actactgggt gttcggcggc ggcaccaagc tgaccgtgct gggcggcggc     1140

ggcagccagg tgcagctgca gcagcccggc agcgagctgg tgaggcccgg cgccagcgtg     1200

aagctgagct gcaaggccag cggctacacc ttcaccagct actggatgca ctgggtgaag     1260

cagaggcccg gccagggcct ggagtggatc ggcaacatct accccaggag cggcaccacc     1320

aactacgacg gctacttcaa gagcaaggcc accctgaccg tggacaccag cagcagcacc     1380

gcctacatgc agctgagcag cctgaccagc gaggacagcg ccgtgtactt ctgcaccagg     1440

agcggctacg actacccctt cgtgtactgg ggccagggca ccctggtgac cgtgagcgcc     1500

accaccaccc ccgcccccag gccccccacc cccgccccca ccatcgccag ccccctgagc     1560

ctgaggcccg aggcctgcag gcccgccgcc ggcggcgccg tgcacaccag gggcctggac     1620

ttcgcctgcg acttctgggt gctggtggtg gtgggcggcg tgctggcctg ctacagcctg     1680

ctggtgaccg tggccttcat catcttctgg gtgaggagca agaggagcag gctgctgcac     1740

agcgactaca tgaacatgac ccccaggagg cccggcccca ccaggaagca ctaccagccc     1800

tacgcccccc ccagggactt cgccgcctac aggagcaggg tgaagttcag caggagcgcc     1860

gacgcccccg cctaccagca gggccagaac cagctgtaca acgagctgaa cctgggcagg     1920

agggaggagt acgacgtgct ggacaagagg aggggcaggg accccgagat gggcggcaag     1980

cccaggagga agaaccccca ggagggcctg tacaacgagc tgcagaagga caagatggcc     2040

gaggcctaca gcgagatcgg catgaagggc gagaggagga ggggcaaggg ccacgacggc     2100

ctgtaccagg gcctgagcac cgccaccaag gacacctacg acgccctgca catgcaggcc     2160

ctgcccccca ggagaaagag aggaagcgga gagggcagag gaagtctgct aacatgcggt     2220

gacgtcgagg agaatcctgg acctatggtg agcaagggcg aggaggataa catggccatc     2280

atcaaggagt tcatgcgctt caaggtgcac atggagggct ccgtgaacgg ccacgagttc     2340

gagatcgagg gcgagggcga gggccgcccc tacgagggca cccagaccgc caagctgaag     2400

gtgaccaagg gtggccccct gcccttcgcc tgggacatcc tgtcccctca gttcatgtac     2460

ggctccaagg cctacgtgaa gcaccccgcc gacatccccg actacttgaa gctgtccttc     2520

cccgagggct tcaagtggga gcgcgtgatg aacttcgagg acggcggcgt ggtgaccgtg     2580

acccaggact cctccctgca ggacggcgag ttcatctaca aggtgaagct gcgcggcacc     2640

aacttcccct ccgacggccc cgtaatgcag aagaagacca tgggctggga ggcctcctcc     2700

gagcggatgt accccgagga cggcgccctg aagggcgaga tcaagcagag gctgaagctg     2760

aaggacggcg gccactacga cgctgaggtc aagaccacct acaaggccaa gaagcccgtg     2820

cagctgcccg gcgcctacaa cgtcaacatc aagttggaca tcacctccca caacgaggac     2880

tacaccatcg tggaacagta cgaacgcgcc gagggccgcc actccaccgg cggcatggac     2940

gagctgtaca agtag                                                      2955


<210> 174
<211> 2955
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 174
atggccctgc ccgtgaccgc cctgctgctg cccctggccc tgctgctgca cgccgccagg       60

ccccaggtgc agctgcagca gcccggcagc gagctggtga ggcccggcgc cagcgtgaag      120

ctgagctgca aggccagcgg ctacaccttc accagctact ggatgcactg ggtgaagcag      180

aggcccggcc agggcctgga gtggatcggc aacatctacc ccaggagcgg caccaccaac      240

tacgacggct acttcaagag caaggccacc ctgaccgtgg acaccagcag cagcaccgcc      300

tacatgcagc tgagcagcct gaccagcgag gacagcgccg tgtacttctg caccaggagc      360

ggctacgact accccttcgt gtactggggc cagggcaccc tggtgaccgt gagcgccggc      420

ggcggcggca gccaggccgt ggtgacccag gagagcgccc tgaccaccag ccccggcgag      480

accgtgaccc tgacctgcag gaccagcacc ggcgccgtga gcatcaggaa ctacgccaac      540

tgggtgcagg agaagcccga ccacctgttc accggcctga tcggcggcac caacaacagg      600

gcccccggcg tgcccgccag gttcagcggc agcctgatcg gcgacaaggc cgccctgacc      660

atcaccggcg cccagcccga ggacgaggcc atctacttct gcgccctgct gtacagcaac      720

tactgggtgt tcggcggcgg caccaagctg accgtgctgg gcggcggcgg cagcggcggc      780

ggcggcagcg gcggcggcgg cagccaggtg cagctgcagc agcccggcag cgagctggtg      840

aggcccggcg ccagcgtgaa gctgagctgc aaggccagcg gctacacctt caccagctac      900

tggatgcact gggtgaagca gaggcccggc cagggcctgg agtggatcgg caacatctac      960

cccaggagcg gcaccaccaa ctacgacggc tacttcaaga gcaaggccac cctgaccgtg     1020

gacaccagca gcagcaccgc ctacatgcag ctgagcagcc tgaccagcga ggacagcgcc     1080

gtgtacttct gcaccaggag cggctacgac taccccttcg tgtactgggg ccagggcacc     1140

ctggtgaccg tgagcgccgg cggcggcggc agccaggccg tggtgaccca ggagagcgcc     1200

ctgaccacca gccccggcga gaccgtgacc ctgacctgca ggaccagcac cggcgccgtg     1260

agcatcagga actacgccaa ctgggtgcag gagaagcccg accacctgtt caccggcctg     1320

atcggcggca ccaacaacag ggcccccggc gtgcccgcca ggttcagcgg cagcctgatc     1380

ggcgacaagg ccgccctgac catcaccggc gcccagcccg aggacgaggc catctacttc     1440

tgcgccctgc tgtacagcaa ctactgggtg ttcggcggcg gcaccaagct gaccgtgctg     1500

accaccaccc ccgcccccag gccccccacc cccgccccca ccatcgccag ccccctgagc     1560

ctgaggcccg aggcctgcag gcccgccgcc ggcggcgccg tgcacaccag gggcctggac     1620

ttcgcctgcg acttctgggt gctggtggtg gtgggcggcg tgctggcctg ctacagcctg     1680

ctggtgaccg tggccttcat catcttctgg gtgaggagca agaggagcag gctgctgcac     1740

agcgactaca tgaacatgac ccccaggagg cccggcccca ccaggaagca ctaccagccc     1800

tacgcccccc ccagggactt cgccgcctac aggagcaggg tgaagttcag caggagcgcc     1860

gacgcccccg cctaccagca gggccagaac cagctgtaca acgagctgaa cctgggcagg     1920

agggaggagt acgacgtgct ggacaagagg aggggcaggg accccgagat gggcggcaag     1980

cccaggagga agaaccccca ggagggcctg tacaacgagc tgcagaagga caagatggcc     2040

gaggcctaca gcgagatcgg catgaagggc gagaggagga ggggcaaggg ccacgacggc     2100

ctgtaccagg gcctgagcac cgccaccaag gacacctacg acgccctgca catgcaggcc     2160

ctgcccccca ggagaaagag aggaagcgga gagggcagag gaagtctgct aacatgcggt     2220

gacgtcgagg agaatcctgg acctatggtg agcaagggcg aggaggataa catggccatc     2280

atcaaggagt tcatgcgctt caaggtgcac atggagggct ccgtgaacgg ccacgagttc     2340

gagatcgagg gcgagggcga gggccgcccc tacgagggca cccagaccgc caagctgaag     2400

gtgaccaagg gtggccccct gcccttcgcc tgggacatcc tgtcccctca gttcatgtac     2460

ggctccaagg cctacgtgaa gcaccccgcc gacatccccg actacttgaa gctgtccttc     2520

cccgagggct tcaagtggga gcgcgtgatg aacttcgagg acggcggcgt ggtgaccgtg     2580

acccaggact cctccctgca ggacggcgag ttcatctaca aggtgaagct gcgcggcacc     2640

aacttcccct ccgacggccc cgtaatgcag aagaagacca tgggctggga ggcctcctcc     2700

gagcggatgt accccgagga cggcgccctg aagggcgaga tcaagcagag gctgaagctg     2760

aaggacggcg gccactacga cgctgaggtc aagaccacct acaaggccaa gaagcccgtg     2820

cagctgcccg gcgcctacaa cgtcaacatc aagttggaca tcacctccca caacgaggac     2880

tacaccatcg tggaacagta cgaacgcgcc gagggccgcc actccaccgg cggcatggac     2940

gagctgtaca agtag                                                      2955


<210> 175
<211> 21
<212> PRT
<213> Homo sapiens

<400> 175
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro 
            20      


<210> 176
<211> 44
<212> PRT
<213> Homo sapiens

<400> 176
Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala 
1               5                   10                  15      


Ser Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly 
            20                  25                  30          


Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp 
        35                  40                  


<210> 177
<211> 12
<212> PRT
<213> Homo sapiens

<400> 177
Glu Ser Lys Tyr Gly Pro Pro Cys Pro Ser Cys Pro 
1               5                   10          


<210> 178
<211> 229
<212> PRT
<213> Homo sapiens

<400> 178
Glu Ser Lys Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Pro Val 
1               5                   10                  15      


Ala Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu 
            20                  25                  30          


Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser 
        35                  40                  45              


Gln Glu Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu 
    50                  55                  60                  


Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Gln Ser Thr 
65                  70                  75                  80  


Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn 
                85                  90                  95      


Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser 
            100                 105                 110         


Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln 
        115                 120                 125             


Val Tyr Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val 
    130                 135                 140                 


Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val 
145                 150                 155                 160 


Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro 
                165                 170                 175     


Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr 
            180                 185                 190         


Val Asp Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val 
        195                 200                 205             


Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu 
    210                 215                 220                 


Ser Leu Gly Lys Met 
225                 


<210> 179
<211> 41
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 179
Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr 
1               5                   10                  15      


Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro 
            20                  25                  30          


Pro Arg Asp Phe Ala Ala Tyr Arg Ser 
        35                  40      


<210> 180
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 180
Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Gln Gln Gly 
1               5                   10                  15      


Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr 
            20                  25                  30          


Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys 
        35                  40                  45              


Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys 
    50                  55                  60                  


Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg 
65                  70                  75                  80  


Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala 
                85                  90                  95      


Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg 
            100                 105                 110         


<210> 181
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 181
Gly Phe Leu Gly 
1               


<210> 182
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 182
Ala Leu Ala Leu 
1               


<210> 183
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 183
Gly Gly Gly Gly Ser 
1               5   


<210> 184
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 184
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  


<210> 185
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 185
Tyr Leu His Leu Gly Ala Leu Gly Arg Asp Leu Trp Gly Pro Ser Pro 
1               5                   10                  15      


Val Thr Gly Tyr His Pro Leu Leu 
            20                  


<210> 186
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 186
Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu 
1               5                   10                  15      


Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val 
            20                  25          


<210> 187
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 187
Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala 
1               5                   10                  15      


Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly 
            20                  25                  30          


Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys 
        35                  40                  


<210> 188
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 188
Ala Pro Thr Ser Ser Ser Gly Gly Gly Gly Ser 
1               5                   10      


<210> 189
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 189
Gly Gly Gly Ser 
1               


<210> 190
<211> 182
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 190
Glu Pro His Ser Leu Arg Tyr Asn Leu Thr Val Leu Ser Trp Asp Gly 
1               5                   10                  15      


Ser Val Gln Ser Gly Phe Leu Thr Glu Val His Leu Asp Gly Gln Pro 
            20                  25                  30          


Phe Leu Arg Cys Asp Arg Gln Lys Cys Arg Ala Lys Pro Gln Gly Gln 
        35                  40                  45              


Trp Ala Glu Asp Val Leu Gly Asn Lys Thr Trp Asp Arg Glu Thr Arg 
    50                  55                  60                  


Asp Leu Thr Gly Trp Gly Thr Thr Leu Leu Met Thr Leu Ala His Ile 
65                  70                  75                  80  


Lys Asp Gln Lys Glu Gly Leu His Ser Leu Gln Glu Ile Arg Val Cys 
                85                  90                  95      


Glu Ile His Glu Asp Asn Ser Thr Arg Ser Ser Gln His Phe Tyr Tyr 
            100                 105                 110         


Asp Gly Glu Leu Phe Leu Ser Gln Asn Leu Glu Thr Leu Glu Trp Thr 
        115                 120                 125             


Met Pro Gln Ser Ser Arg Ala Gln Thr Leu Ala Met Asn Val Arg Asn 
    130                 135                 140                 


Phe Leu Lys Glu Asp Ala Met Glu Thr Asp Ile Gly Tyr Arg Leu Met 
145                 150                 155                 160 


Arg Ala Asp Cys Leu Ser Glu Leu Arg Arg Tyr Leu Lys Ser Gly Val 
                165                 170                 175     


Val Leu Arg Arg Thr Val 
            180         


<210> 191
<211> 182
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 191
Glu Pro His Ser Leu Arg Tyr Asn Leu Thr Val Leu Ser Trp Asp Gly 
1               5                   10                  15      


Ser Val Gln Ser Gly Phe Leu Thr Glu Val His Leu Asp Gly Gln Pro 
            20                  25                  30          


Phe Leu Arg Cys Asp Arg Gln Lys Cys Arg Ala Lys Pro Gln Gly Gln 
        35                  40                  45              


Trp Ala Glu Asp Val Leu Gly Asn Lys Thr Trp Asp Arg Glu Thr Arg 
    50                  55                  60                  


Asp Leu Thr Gly Trp Gly Thr Phe Leu Arg Met Thr Leu Ala His Ile 
65                  70                  75                  80  


Lys Asp Gln Lys Glu Gly Leu His Ser Leu Gln Glu Ile Arg Val Cys 
                85                  90                  95      


Glu Ile His Glu Asp Asn Ser Thr Arg Ser Ser Gln His Phe Tyr Tyr 
            100                 105                 110         


Asp Gly Glu Leu Phe Leu Ser Gln Asn Leu Glu Thr Leu Glu Trp Thr 
        115                 120                 125             


Met Pro Gln Ser Ser Arg Ala Gln Thr Leu Ala Met Asn Val Arg Asn 
    130                 135                 140                 


Phe Leu Lys Glu Asp Ala Met Glu Thr Asp Arg Ser Gly Leu Leu Met 
145                 150                 155                 160 


Arg Ala Asp Cys Leu Ser Glu Leu Arg Arg Tyr Leu Lys Ser Gly Val 
                165                 170                 175     


Val Leu Arg Arg Thr Val 
            180         


<210> 192
<211> 186
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 192
Ala Ala Glu Pro His Ser Leu Ser Tyr Asp Ile Thr Val Ile Pro Lys 
1               5                   10                  15      


Phe Arg Pro Gly Pro Arg Trp Cys Ala Val Gln Gly Gln Val Asp Glu 
            20                  25                  30          


Lys Thr Phe Leu His Tyr Asp Cys Gly Asn Lys Thr Val Thr Pro Val 
        35                  40                  45              


Ser Pro Leu Gly Lys Lys Leu Asn Val Thr Thr Ala Trp Lys Ala Gln 
    50                  55                  60                  


Asn Pro Val Leu Arg Glu Val Val Asp Ile Leu Thr Glu Gln Leu Trp 
65                  70                  75                  80  


Asp Ile Gln Leu Glu Asn Tyr Thr Pro Lys Glu Pro Leu Thr Leu Gln 
                85                  90                  95      


Ala Arg Met Ser Cys Glu Gln Lys Ala Glu Gly His Ser Ser Gly Ser 
            100                 105                 110         


Trp Gln Phe Ser Phe Asp Gly Gln Ile Phe Leu Leu Phe Asp Ser Glu 
        115                 120                 125             


Lys Arg Met Trp Thr Thr Val His Pro Gly Ala Arg Lys Met Lys Glu 
    130                 135                 140                 


Lys Trp Glu Asn Asp Lys Val Val Ala Thr Thr Leu Tyr Thr Trp Ser 
145                 150                 155                 160 


Met Gly Asp Cys Ile Gly Trp Leu Glu Asp Phe Leu Met Gly Met Asp 
                165                 170                 175     


Ser Thr Leu Glu Pro Ser Ala Gly Ala Pro 
            180                 185     


<210> 193
<211> 186
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 193
Ala Ala Glu Pro His Ser Leu Ser Tyr Asp Ile Thr Val Ile Pro Lys 
1               5                   10                  15      


Phe Arg Pro Gly Pro Arg Trp Cys Ala Val Gln Gly Gln Val Asp Glu 
            20                  25                  30          


Lys Thr Phe Leu His Tyr Asp Cys Gly Asn Lys Thr Val Thr Pro Val 
        35                  40                  45              


Ser Pro Leu Gly Lys Lys Leu Asn Val Thr Thr Ala Trp Lys Ala Gln 
    50                  55                  60                  


Asn Pro Val Leu Arg Glu Val Val Asp Ile Leu Thr Glu Gln Leu Trp 
65                  70                  75                  80  


Asp Ile Gln Leu Glu Asn Tyr Thr Pro Lys Glu Pro Leu Thr Leu Gln 
                85                  90                  95      


Ala Arg Met Ser Cys Glu Gln Lys Ala Glu Gly His Ser Ser Gly Ser 
            100                 105                 110         


Trp Gln Phe Ser Phe Asp Gly Gln Ile Phe Leu Leu Phe Asp Ser Glu 
        115                 120                 125             


Lys Arg Met Trp Thr Thr Val His Pro Gly Ala Arg Lys Met Lys Glu 
    130                 135                 140                 


Lys Trp Glu Asn Asp Lys Val Val Ala Thr Leu Met Arg Ile Trp Ser 
145                 150                 155                 160 


Met Gly Asp Cys Ile Gly Trp Leu Glu Asp Phe Leu Met Gly Met Asp 
                165                 170                 175     


Ser Thr Leu Glu Pro Ser Ala Gly Ala Pro 
            180                 185     


<210> 194
<211> 186
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 194
Ala Ala Glu Pro His Ser Leu Ser Tyr Asp Ile Thr Val Ile Pro Lys 
1               5                   10                  15      


Phe Arg Pro Gly Pro Arg Trp Cys Ala Val Gln Gly Gln Val Asp Glu 
            20                  25                  30          


Lys Thr Phe Leu His Tyr Asp Cys Gly Asn Lys Thr Val Thr Pro Val 
        35                  40                  45              


Ser Pro Leu Gly Lys Lys Leu Asn Val Thr Thr Ala Trp Lys Ala Gln 
    50                  55                  60                  


Asn Pro Val Leu Arg Glu Val Val Asp Ile Leu Thr Glu Gln Leu Trp 
65                  70                  75                  80  


Asp Ile Gln Leu Glu Asn Tyr Thr Pro Lys Glu Pro Leu Thr Leu Gln 
                85                  90                  95      


Ala Arg Met Ser Cys Glu Gln Lys Ala Glu Gly His Ser Ser Gly Ser 
            100                 105                 110         


Trp Gln Phe Ser Phe Asp Gly Gln Ile Phe Leu Leu Phe Asp Ser Glu 
        115                 120                 125             


Lys Arg Met Trp Thr Thr Val His Pro Gly Ala Arg Lys Met Lys Glu 
    130                 135                 140                 


Lys Trp Glu Asn Asp Lys Val Val Ala Thr Lys Leu Tyr Leu Trp Ser 
145                 150                 155                 160 


Met Gly Asp Cys Ile Gly Trp Leu Glu Asp Phe Leu Met Gly Met Asp 
                165                 170                 175     


Ser Thr Leu Glu Pro Ser Ala Gly Ala Pro 
            180                 185     


<210> 195
<211> 184
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 195
Ala Ala Glu Pro His Ser Leu Trp Tyr Asn Phe Thr Ile Ile His Leu 
1               5                   10                  15      


Pro Arg His Gly Gln Gln Trp Cys Glu Val Gln Ser Gln Val Asp Gln 
            20                  25                  30          


Lys Asn Phe Leu Ser Tyr Asp Cys Gly Ser Asp Lys Val Leu Ser Met 
        35                  40                  45              


Gly His Leu Glu Glu Gln Leu Tyr Ala Thr Asp Ala Trp Gly Lys Gln 
    50                  55                  60                  


Leu Glu Met Leu Arg Glu Val Gly Gln Arg Leu Arg Leu Glu Leu Ala 
65                  70                  75                  80  


Asp Thr Glu Leu Glu Asp Phe Thr Pro Ser Gly Pro Leu Thr Leu Gln 
                85                  90                  95      


Val Arg Met Ser Cys Glu Ser Glu Ala Asp Gly Tyr Ile Arg Gly Ser 
            100                 105                 110         


Trp Gln Phe Ser Phe Asp Gly Arg Lys Phe Leu Leu Phe Asp Ser Asn 
        115                 120                 125             


Asn Arg Lys Trp Thr Val Val His Ala Gly Ala Arg Arg Met Lys Glu 
    130                 135                 140                 


Lys Trp Glu Lys Asp Ser Gly Leu Thr Thr Asp Leu Ile Arg Arg Ser 
145                 150                 155                 160 


Met Gly Asp Cys Lys Ser Trp Leu Arg Asp Phe Leu Met His Arg Lys 
                165                 170                 175     


Lys Arg Leu Glu Pro Thr Ala Pro 
            180                 


<210> 196
<211> 184
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 196
Ala Ala Glu Pro His Ser Leu Trp Tyr Asn Phe Thr Ile Ile His Leu 
1               5                   10                  15      


Pro Arg His Gly Gln Gln Trp Cys Glu Val Gln Ser Gln Val Asp Gln 
            20                  25                  30          


Lys Asn Phe Leu Ser Tyr Asp Cys Gly Ser Asp Lys Val Leu Ser Met 
        35                  40                  45              


Gly His Leu Glu Glu Gln Leu Tyr Ala Thr Asp Ala Trp Gly Lys Gln 
    50                  55                  60                  


Leu Glu Met Leu Arg Glu Val Gly Gln Arg Leu Arg Leu Glu Leu Ala 
65                  70                  75                  80  


Asp Thr Glu Leu Glu Asp Phe Thr Pro Ser Gly Pro Leu Thr Leu Gln 
                85                  90                  95      


Val Arg Met Ser Cys Glu Ser Glu Ala Asp Gly Tyr Ile Arg Gly Ser 
            100                 105                 110         


Trp Gln Phe Ser Phe Asp Gly Arg Lys Phe Leu Leu Phe Asp Ser Asn 
        115                 120                 125             


Asn Arg Lys Trp Thr Val Val His Ala Gly Ala Arg Arg Met Lys Glu 
    130                 135                 140                 


Lys Trp Glu Lys Asp Ser Gly Leu Thr Thr Tyr Phe Tyr Leu Arg Ser 
145                 150                 155                 160 


Met Gly Asp Cys Lys Ser Trp Leu Arg Asp Phe Leu Met His Arg Lys 
                165                 170                 175     


Lys Arg Leu Glu Pro Thr Ala Pro 
            180                 


<210> 197
<211> 180
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 197
Glu Pro His Ser Leu Ser Tyr Asp Ile Thr Val Ile Pro Lys Phe Arg 
1               5                   10                  15      


Pro Gly Pro Arg Trp Cys Ala Val Gln Gly Gln Val Asp Glu Lys Thr 
            20                  25                  30          


Phe Leu His Tyr Asp Cys Gly Asn Lys Thr Val Thr Pro Val Ser Pro 
        35                  40                  45              


Leu Gly Lys Lys Leu Asn Val Thr Thr Ala Trp Lys Ala Gln Asn Pro 
    50                  55                  60                  


Val Leu Arg Glu Val Val Asp Ile Leu Thr Glu Gln Leu Trp Asp Ile 
65                  70                  75                  80  


Gln Leu Glu Asn Tyr Thr Pro Lys Glu Pro Leu Thr Leu Gln Ala Arg 
                85                  90                  95      


Met Ser Cys Glu Gln Lys Ala Glu Gly His Ser Ser Gly Ser Trp Gln 
            100                 105                 110         


Phe Ser Phe Asp Gly Gln Ile Phe Leu Leu Phe Asp Ser Glu Lys Arg 
        115                 120                 125             


Met Trp Thr Thr Val His Pro Gly Ala Arg Lys Met Lys Glu Lys Trp 
    130                 135                 140                 


Glu Asn Asp Lys Val Val Ala Thr Ile Leu Trp Gln Thr Ser Met Gly 
145                 150                 155                 160 


Asp Cys Ile Gly Trp Leu Glu Asp Phe Leu Met Gly Met Asp Ser Thr 
                165                 170                 175     


Leu Glu Pro Ser 
            180 


<210> 198
<211> 180
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 198
Glu Pro His Ser Leu Ser Tyr Asp Ile Thr Val Ile Pro Lys Phe Arg 
1               5                   10                  15      


Pro Gly Pro Arg Trp Cys Ala Val Gln Gly Gln Val Asp Glu Lys Thr 
            20                  25                  30          


Phe Leu His Tyr Asp Cys Gly Asn Lys Thr Val Thr Pro Val Ser Pro 
        35                  40                  45              


Leu Gly Lys Lys Leu Asn Val Thr Thr Ala Trp Lys Ala Gln Asn Pro 
    50                  55                  60                  


Val Leu Arg Glu Val Val Asp Ile Leu Thr Glu Gln Leu Trp Asp Ile 
65                  70                  75                  80  


Gln Leu Glu Asn Tyr Thr Pro Lys Glu Pro Leu Thr Leu Gln Ala Arg 
                85                  90                  95      


Met Ser Cys Glu Gln Lys Ala Glu Gly His Ser Ser Gly Ser Trp Gln 
            100                 105                 110         


Phe Ser Phe Asp Gly Gln Ile Phe Leu Leu Phe Asp Ser Glu Lys Arg 
        115                 120                 125             


Met Trp Thr Thr Val His Pro Gly Ala Arg Lys Met Lys Glu Lys Trp 
    130                 135                 140                 


Glu Asn Asp Lys Val Val Ala Thr Leu Leu Trp Gly Trp Ser Met Gly 
145                 150                 155                 160 


Asp Cys Ile Gly Trp Leu Glu Asp Phe Leu Met Gly Met Asp Ser Thr 
                165                 170                 175     


Leu Glu Pro Ser 
            180 


<210> 199
<211> 180
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 199
Glu Pro His Ser Leu Ser Tyr Asp Ile Thr Val Ile Pro Lys Phe Arg 
1               5                   10                  15      


Pro Gly Pro Arg Trp Cys Ala Val Gln Gly Gln Val Asp Glu Lys Thr 
            20                  25                  30          


Phe Leu His Tyr Asp Cys Gly Asn Lys Thr Val Thr Pro Val Ser Pro 
        35                  40                  45              


Leu Gly Lys Lys Leu Asn Val Thr Thr Ala Trp Lys Ala Gln Asn Pro 
    50                  55                  60                  


Val Leu Arg Glu Val Val Asp Ile Leu Thr Glu Gln Leu Trp Asp Ile 
65                  70                  75                  80  


Gln Leu Glu Asn Tyr Thr Pro Lys Glu Pro Leu Thr Leu Gln Ala Arg 
                85                  90                  95      


Met Ser Cys Glu Gln Lys Ala Glu Gly His Ser Ser Gly Ser Trp Gln 
            100                 105                 110         


Phe Ser Phe Asp Gly Gln Ile Phe Leu Leu Phe Asp Ser Glu Lys Arg 
        115                 120                 125             


Met Trp Thr Thr Val His Pro Gly Ala Arg Lys Met Lys Glu Lys Trp 
    130                 135                 140                 


Glu Asn Asp Lys Val Val Ala Thr Met Phe Trp Ser Trp Ser Met Gly 
145                 150                 155                 160 


Asp Cys Ile Gly Trp Leu Glu Asp Phe Leu Met Gly Met Asp Ser Thr 
                165                 170                 175     


Leu Glu Pro Ser 
            180 


<210> 200
<211> 180
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 200
Glu Pro His Ser Leu Ser Tyr Asp Ile Thr Val Ile Pro Lys Phe Arg 
1               5                   10                  15      


Pro Gly Pro Arg Trp Cys Ala Val Gln Gly Gln Val Asp Glu Lys Thr 
            20                  25                  30          


Phe Leu His Tyr Asp Cys Gly Asn Lys Thr Val Thr Pro Val Ser Pro 
        35                  40                  45              


Leu Gly Lys Lys Leu Asn Val Thr Thr Ala Trp Lys Ala Gln Asn Pro 
    50                  55                  60                  


Val Leu Arg Glu Val Val Asp Ile Leu Thr Glu Gln Leu Trp Asp Ile 
65                  70                  75                  80  


Gln Leu Glu Asn Tyr Thr Pro Lys Glu Pro Leu Thr Leu Gln Ala Arg 
                85                  90                  95      


Met Ser Cys Glu Gln Lys Ala Glu Gly His Ser Ser Gly Ser Trp Gln 
            100                 105                 110         


Phe Ser Phe Asp Gly Gln Ile Phe Leu Leu Phe Asp Ser Glu Lys Arg 
        115                 120                 125             


Met Trp Thr Thr Val His Pro Gly Ala Arg Lys Met Lys Glu Lys Trp 
    130                 135                 140                 


Glu Asn Asp Lys Val Val Ala Thr Leu Met Trp Gln Trp Ser Met Gly 
145                 150                 155                 160 


Asp Cys Ile Gly Trp Leu Glu Asp Phe Leu Met Gly Met Asp Ser Thr 
                165                 170                 175     


Leu Glu Pro Ser 
            180 


<210> 201
<211> 137
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 201
Asn Ser Leu Phe Asn Gln Glu Val Gln Ile Pro Leu Thr Glu Ser Tyr 
1               5                   10                  15      


Cys Gly Pro Cys Pro Lys Asn Trp Ile Cys Tyr Lys Asn Asn Cys Tyr 
            20                  25                  30          


Gln Phe Phe Asp Glu Ser Lys Asn Trp Tyr Glu Ser Gln Ala Ser Cys 
        35                  40                  45              


Met Ser Gln Asn Ala Ser Leu Leu Lys Val Tyr Ser Lys Glu Asp Gln 
    50                  55                  60                  


Asp Leu Leu Lys Leu Val Lys Ser Tyr His Trp Met Gly Leu Val His 
65                  70                  75                  80  


Ile Pro Thr Asn Gly Ser Trp Gln Trp Glu Asp Gly Ser Ile Leu Ser 
                85                  90                  95      


Pro Asn Leu Leu Thr Ile Ile Glu Met Gln Lys Gly Asp Cys Ala Leu 
            100                 105                 110         


Tyr Ala Ser Ser Phe Lys Gly Tyr Ile Glu Asn Cys Ser Thr Pro Asn 
        115                 120                 125             


Thr Tyr Ile Cys Met Gln Arg Thr Val 
    130                 135         


<210> 202
<211> 139
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 202
Phe Leu Asn Ser Leu Phe Asn Gln Glu Val Gln Ile Pro Leu Thr Glu 
1               5                   10                  15      


Ser Tyr Cys Gly Pro Cys Pro Lys Asn Trp Ile Cys Tyr Lys Asn Asn 
            20                  25                  30          


Cys Tyr Gln Phe Phe Asp Glu Ser Lys Asn Trp Tyr Glu Ser Gln Ala 
        35                  40                  45              


Ser Cys Met Ser Gln Asn Ala Ser Leu Leu Lys Val Tyr Ser Lys Glu 
    50                  55                  60                  


Asp Gln Asp Leu Leu Lys Leu Val Lys Ser Tyr His Trp Met Gly Leu 
65                  70                  75                  80  


Val His Ile Pro Thr Asn Gly Ser Trp Gln Trp Glu Asp Gly Ser Ile 
                85                  90                  95      


Leu Ser Pro Asn Leu Leu Thr Ile Ile Glu Met Gln Lys Gly Asp Cys 
            100                 105                 110         


Ala Leu Tyr Ala Ser Ser Phe Lys Gly Tyr Ile Glu Asn Cys Ser Thr 
        115                 120                 125             


Pro Asn Thr Tyr Ile Cys Met Gln Arg Thr Val 
    130                 135                 


<210> 203
<211> 43
<212> PRT
<213> Homo sapiens

<400> 203
Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala 
1               5                   10                  15      


Ser Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly 
            20                  25                  30          


Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys 
        35                  40              


<210> 204
<211> 70
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"


<220>
<221> misc_feature
<222> (1)..(70)
<223> /note="The sequence can include 50-70 nucleotides"

<400> 204
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa       60

aaaaaaaaaa                                                              70


<210> 205
<211> 60
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 205
Val Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro 
1               5                   10                  15      


Pro Ala His Gly Val Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly 
            20                  25                  30          


Ser Thr Ala Pro Pro Ala His Gly Val Thr Ser Ala Pro Asp Thr Arg 
        35                  40                  45              


Pro Ala Pro Gly Ser Thr Ala Pro Pro Ala His Gly 
    50                  55                  60  


<210> 206
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 206
Gln Ser Leu Glu Glu Ser Gly Gly Arg Leu Val Thr Pro Gly Thr Pro 
1               5                   10                  15      


Leu Thr Leu Thr Cys Thr Ala Ser Gly Phe Thr Ile Asn Thr Tyr His 
            20                  25                  30          


Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Gln Tyr Ile Gly 
        35                  40                  45              


Ile Val Ser His Asp Val Gly Thr Tyr Tyr Ala Thr Trp Ala Lys Gly 
    50                  55                  60                  


Arg Phe Thr Ile Ser Lys Thr Ser Ser Thr Thr Val Asp Leu Arg Met 
65                  70                  75                  80  


Pro Ser Pro Thr Thr Glu Asp Thr Ala Thr Tyr Ile Cys Ala Arg Gly 
                85                  90                  95      


Pro Gly Tyr Trp Thr Phe Asn Leu Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210> 207
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 207
Ala Gln Val Leu Thr Gln Thr Pro Ala Ser Val Ser Ala Ala Val Gly 
1               5                   10                  15      


Gly Thr Val Thr Ile Asn Cys Gln Ala Ser Gln Ser Val Tyr Asn Asn 
            20                  25                  30          


Asn Gln Leu Ser Trp Tyr Gln Gln Lys Pro Gly Gln Pro Leu Lys Gln 
        35                  40                  45              


Leu Ile Tyr Lys Ala Ser Thr Leu Ala Ser Gly Val Pro Ser Arg Phe 
    50                  55                  60                  


Lys Gly Ser Gly Ser Gly Ser Gln Phe Thr Leu Thr Ile Ser Asp Leu 
65                  70                  75                  80  


Glu Cys Asp Asp Ala Ala Thr Tyr Phe Cys Ala Gly Gly Tyr Lys Gly 
                85                  90                  95      


Asp Ile His Pro Phe Gly Gly Gly Thr Glu Val Val Val Lys 
            100                 105                 110 


<210> 208
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 208
Gly Phe Thr Ile Asn Thr Tyr His 
1               5               


<210> 209
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 209
Val Ser His Asp Val Gly Thr 
1               5           


<210> 210
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 210
Ala Arg Gly Pro Gly Tyr Trp Thr Phe Asn Leu 
1               5                   10      


<210> 211
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 211
Gln Ser Val Tyr Asn Asn Asn Gln 
1               5               


<210> 212
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 212
Lys Ala Ser 
1           


<210> 213
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 213
Ala Gly Gly Tyr Lys Gly Asp Ile His Pro 
1               5                   10  


<210> 214
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 214
Thr Tyr His Met Gly 
1               5   


<210> 215
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 215
Ile Val Ser His Asp Val Gly Thr Tyr Tyr Ala Thr Trp Ala Lys Gly 
1               5                   10                  15      


<210> 216
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 216
Gly Pro Gly Tyr Trp Thr Phe Asn Leu 
1               5                   


<210> 217
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 217
Gln Ala Ser Gln Ser Val Tyr Asn Asn Asn Gln Leu Ser 
1               5                   10              


<210> 218
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 218
Lys Ala Ser Thr Leu Ala Ser 
1               5           


<210> 219
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 219
Ala Gly Gly Tyr Lys Gly Asp Ile His Pro 
1               5                   10  


<210> 220
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 220
Gly Phe Thr Ile Asn Thr Tyr 
1               5           


<210> 221
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 221
Ser His Asp Val Gly 
1               5   


<210> 222
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 222
Gly Pro Gly Tyr Trp Thr Phe Asn Leu 
1               5                   


<210> 223
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 223
Gln Ala Ser Gln Ser Val Tyr Asn Asn Asn Gln Leu Ser 
1               5                   10              


<210> 224
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 224
Lys Ala Ser Thr Leu Ala Ser 
1               5           


<210> 225
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 225
Ala Gly Gly Tyr Lys Gly Asp Ile His Pro 
1               5                   10  


<210> 226
<211> 345
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 226
cagagcctgg aggagagcgg cggcaggctg gtgacccccg gcacccccct gaccctgacc       60

tgcaccgcca gcggcttcac catcaacacc taccacatgg gctggttcag gcaggccccc      120

ggcaagggcc tgcagtacat cggcatcgtg agccacgacg tgggcaccta ctacgccacc      180

tgggccaagg gcaggttcac catcagcaag accagcagca ccaccgtgga cctgaggatg      240

cccagcccca ccaccgagga caccgccacc tacatctgcg ccaggggccc cggctactgg      300

accttcaacc tgtggggcca gggcaccctg gtgaccgtga gcagc                      345


<210> 227
<211> 330
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 227
gcccaggtgc tgacccagac ccccgccagc gtgagcgccg ccgtgggcgg caccgtgacc       60

atcaactgcc aggccagcca gagcgtgtac aacaacaacc agctgagctg gtaccagcag      120

aagcccggcc agcccctgaa gcagctgatc tacaaggcca gcaccctggc cagcggcgtg      180

cccagcaggt tcaagggcag cggcagcggc agccagttca ccctgaccat cagcgacctg      240

gagtgcgacg acgccgccac ctacttctgc gccggcggct acaagggcga catccacccc      300

ttcggcggcg gcaccgaggt ggtggtgaag                                       330


<210> 228
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser" or "Asn"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Ala" or "Gly" or "His"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 228
Gly Tyr Thr Phe Thr Ser Phe Trp 
1               5               


<210> 229
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ser" or "His"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Asp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ile" or " "

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 229
Tyr Pro Arg Ser Gly Thr Thr 
1               5           


<210> 230
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu" or "Lys"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile" or "Ala"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 230
Gly Thr Asn 
1           


<210> 231
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln" or "Gly"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His" or "Lys"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln" or "Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro" or "Asp"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe" or "Ile"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace=" "

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 231
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr Pro 
1               5                   10  


<210> 232
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ala" or "Gly" or "His"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser" or "Gly"

<220>
<221> SITE
<222> (1)..(5)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 232
Ser Tyr Trp Met His 
1               5   


<210> 233
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Glu" or "Tyr" or "Ile"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Val"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "His"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Gly" or "Asp"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Ile" or " "

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Pro" or "Ala"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Asp" or "Thr"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Thr" or "Trp"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Val" or "Ala"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="Gly"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 233
Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Lys 
1               5                   10                  15      


Ser 
    


<210> 234
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu" or "Lys"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile" or "Ala"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Arg" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Leu"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="His" or "Phe"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 234
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 235
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln" or "Gly"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His" or "Lys"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln" or "Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro" or "Asp"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe" or "Ile"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace=" "

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 235
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr Pro 
1               5                   10  


<210> 236
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser" or "Asn"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Phe"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 236
Gly Tyr Thr Phe Thr Ser Tyr 
1               5           


<210> 237
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ser" or "His"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Asp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Tyr"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 237
Tyr Pro Arg Ser Gly Thr 
1               5       


<210> 238
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu" or "Lys"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile" or "Ala"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Arg" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Leu"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="His" or "Phe"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 238
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 239
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln" or "Gly"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His" or "Lys"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln" or "Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro" or "Asp"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe" or "Ile"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace=" "

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 239
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr Pro 
1               5                   10  


<210> 240
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 240
Gly Phe Thr Ile Asn Thr Tyr His Met Gly 
1               5                   10  


<210> 241
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 241
Ile Val Ser His Asp Val Gly Thr Tyr Tyr Ala Thr Trp Ala Lys Gly 
1               5                   10                  15      


<210> 242
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 242
Ala Arg Gly Pro Gly Tyr Trp Thr Phe Asn Leu 
1               5                   10      


<210> 243
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 243
Gln Ala Ser Gln Ser Val Tyr Asn Asn Asn Gln Leu Ser 
1               5                   10              


<210> 244
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 244
Lys Ala Ser Thr Leu Ala Ser 
1               5           


<210> 245
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 245
Ala Gly Gly Tyr Lys Gly Asp Ile His Pro 
1               5                   10  


<210> 246
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser" or "Asn"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Phe"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Ala" or "Gly" or "His"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Ile"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Ser" or "Gly"

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 246
Gly Tyr Thr Phe Thr Ser Tyr Trp Met His 
1               5                   10  


<210> 247
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Glu" or "Tyr" or "Ile"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Val"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "His"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Gly" or "Asp"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Ile" or " "

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Pro" or "Ala"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Asp" or "Thr"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Thr" or "Trp"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Val" or "Ala"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="Gly"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 247
Asn Ile Tyr Pro Arg Ser Gly Thr Thr Asn Tyr Asp Gly Tyr Phe Lys 
1               5                   10                  15      


Ser 
    


<210> 248
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu" or "Lys"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile" or "Ala"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Arg" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Leu"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="His" or "Phe"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(7)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 248
Gly Thr Asn Asn Arg Ala Pro 
1               5           


<210> 249
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln" or "Gly"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His" or "Lys"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln" or "Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro" or "Asp"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe" or "Ile"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr" or "His"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace=" "

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 249
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr Pro 
1               5                   10  


<210> 250
<211> 2
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 250
Thr Tyr 
1       


<210> 251
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 251
Ser His Asp Val Gly 
1               5   


<210> 252
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 252
Gly Pro Gly Tyr Trp Thr Phe Asn Leu 
1               5                   


<210> 253
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 253
Gln Ser Val Tyr Asn Asn Asn Gln 
1               5               


<210> 254
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 254
Lys Ala Ser 
1           


<210> 255
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 255
Ala Gly Gly Tyr Lys Gly Asp Ile His Pro 
1               5                   10  


<210> 256
<211> 2
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Phe"

<220>
<221> SITE
<222> (1)..(2)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 256
Ser Tyr 
1       


<210> 257
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ser" or "His"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Asp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gly"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Tyr"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 257
Tyr Pro Arg Ser Gly Thr 
1               5       


<210> 258
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Ser" or "Leu" or "Lys"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile" or "Ala"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 258
Gly Thr Asn 
1           


<210> 259
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Leu"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gln" or "Gly"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Gly" or "Trp"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ser" or "Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Thr" or "His" or "Lys"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Gln" or "Gly"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Pro" or "Asp"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Phe" or "Ile"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Thr" or "His"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 259
Ala Leu Leu Tyr Ser Asn Tyr Trp Tyr 
1               5                   


<210> 260
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Glycosylated Thr

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Glycosylated Ser

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Glycosylated Thr

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Glycosylated Ser

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Glycosylated Thr

<400> 260
Thr Ala Pro Pro Ala His Gly Val Xaa Xaa Ala Pro Asp Xaa Arg Pro 
1               5                   10                  15      


Ala Pro Gly Xaa Xaa Ala Pro Pro Ala His Gly Val Thr 
            20                  25                  


<210> 261
<211> 1488
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 261
atggctctgc ctgtcaccgc gctgctcctt cccttagccc tgctgctgca cgctgctcgt       60

ccagcgcagg tcctgactca gacacccgcg tccgtgtccg cagcggtcgg gggcactgtg      120

accatcaact gccaggcaag ccagtccgtg tacaataaca accagctgag ttggtaccaa      180

cagaagcctg ggcagcccct aaagcagctg atttacaagg cttccaccct tgcttccggc      240

gtcccctcta ggtttaaggg ctctgggagc ggttcccagt tcaccctgac catcagcgat      300

ctggaatgcg atgacgccgc cacctacttc tgtgccggcg gctacaaggg ggacatccac      360

cccttcggtg gcggtactga ggtggtagtc aagggagacc cggtgggcgg tggcggctcc      420

ggaggcggtg gttctggtgg aggaggcagc cagtgtcagt ctctggagga gagcgggggc      480

cgcctggtga cccccggtac tccgctcact ctgacctgca ctgcatctgg cttcaccatt      540

aacacgtacc acatgggatg gttccgccag gcccctggca agggcctcca gtatattggc      600

atcgtgagtc atgacgtggg cacctactac gctacctggg caaaaggacg cttcacgatc      660

tccaagacct cctcgaccac agtggacctg cgcatgccca gcccaacgac cgaggacacc      720

gccacttaca tctgcgcccg tgggccgggc tattggacct tcaacctgtg gggccagggc      780

accctggtga cagtttcctc gggacagcca aagaccacaa cccccgcccc gcgccctcct      840

accccggccc ctacgatagc gtcacccctg tctctccgcc ccgaggcttg taggcctgcc      900

gctggtgggg ccgtccacac ccgtggcttg gatttcgctt gcgacttctg ggtcttggtg      960

gtggtggggg gagtgctggc gtgttactcg ttgctggtca ccgtggcgtt catcatcttc     1020

tgggtacgca gcaagcgcag ccgtctcctg cactccgact acatgaatat gacacctaga     1080

cggcccggcc ctacccggaa gcactaccag ccctatgctc ccccgaggga ctttgctgcg     1140

taccgctccc gcgtgaaatt ttcacgctcc gcggacgctc cggcctatca gcagggtcag     1200

aaccagcttt acaacgagct caacctgggc cgacgtgaag agtacgatgt gctggacaag     1260

cgccggggac gcgatccaga gatgggcggc aagcccagac gcaagaaccc tcaggagggc     1320

ttgtacaacg agctgcagaa ggacaaaatg gccgaggcct actccgagat cggtatgaag     1380

ggggagcggc gccgcggcaa aggccacgac ggcctctatc aggggctttc gaccgccact     1440

aaggacacct acgacgcact tcatatgcaa gccctgcccc cgcgctag                  1488


<210> 262
<211> 495
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 262
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Ala Gln Val Leu Thr Gln Thr Pro Ala Ser Val 
            20                  25                  30          


Ser Ala Ala Val Gly Gly Thr Val Thr Ile Asn Cys Gln Ala Ser Gln 
        35                  40                  45              


Ser Val Tyr Asn Asn Asn Gln Leu Ser Trp Tyr Gln Gln Lys Pro Gly 
    50                  55                  60                  


Gln Pro Leu Lys Gln Leu Ile Tyr Lys Ala Ser Thr Leu Ala Ser Gly 
65                  70                  75                  80  


Val Pro Ser Arg Phe Lys Gly Ser Gly Ser Gly Ser Gln Phe Thr Leu 
                85                  90                  95      


Thr Ile Ser Asp Leu Glu Cys Asp Asp Ala Ala Thr Tyr Phe Cys Ala 
            100                 105                 110         


Gly Gly Tyr Lys Gly Asp Ile His Pro Phe Gly Gly Gly Thr Glu Val 
        115                 120                 125             


Val Val Lys Gly Asp Pro Val Gly Gly Gly Gly Ser Gly Gly Gly Gly 
    130                 135                 140                 


Ser Gly Gly Gly Gly Ser Gln Cys Gln Ser Leu Glu Glu Ser Gly Gly 
145                 150                 155                 160 


Arg Leu Val Thr Pro Gly Thr Pro Leu Thr Leu Thr Cys Thr Ala Ser 
                165                 170                 175     


Gly Phe Thr Ile Asn Thr Tyr His Met Gly Trp Phe Arg Gln Ala Pro 
            180                 185                 190         


Gly Lys Gly Leu Gln Tyr Ile Gly Ile Val Ser His Asp Val Gly Thr 
        195                 200                 205             


Tyr Tyr Ala Thr Trp Ala Lys Gly Arg Phe Thr Ile Ser Lys Thr Ser 
    210                 215                 220                 


Ser Thr Thr Val Asp Leu Arg Met Pro Ser Pro Thr Thr Glu Asp Thr 
225                 230                 235                 240 


Ala Thr Tyr Ile Cys Ala Arg Gly Pro Gly Tyr Trp Thr Phe Asn Leu 
                245                 250                 255     


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gln Pro Lys Thr 
            260                 265                 270         


Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser 
        275                 280                 285             


Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala 
    290                 295                 300                 


Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Phe Trp Val Leu Val 
305                 310                 315                 320 


Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu Leu Val Thr Val Ala 
                325                 330                 335     


Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser Arg Leu Leu His Ser 
            340                 345                 350         


Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His 
        355                 360                 365             


Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Arg 
    370                 375                 380                 


Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Gln Gln Gly Gln 
385                 390                 395                 400 


Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr Asp 
                405                 410                 415     


Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys Pro 
            420                 425                 430         


Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys Asp 
        435                 440                 445             


Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg Arg 
    450                 455                 460                 


Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala Thr 
465                 470                 475                 480 


Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg 
                485                 490                 495 


